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Multidrug-resistant organisms (MDRO) are a global problem, causing treatment challenges 
which result in worse health outcomes and high healthcare costs. As resistance to antibiotics 
continues to develop causing treatment failures, infection prevention strategies have become 
necessary. This dissertation offers research into discovering potential targets for intervention of 
MDRO acquisition through prevention of multiple MDRO colonization and infection and 
prevention of infection and transmission through the environment. The introduction for these 
topics will be covered in chapter one. 
 In chapter two, we analyzed a four-year, prospective study to identify risk factors among 
hospitalized patients for co-colonization and coinfection (CCCI) with methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), a predecessor to 
vancomycin-resistant S. aureus. Using conditional logistic regression, we identified admission 
from another healthcare facility as a risk factor when comparing CCCI patients to patients with 
MRSA only and patients without MRSA or VRE, indicating healthcare exposure increases the risk 
of CCCI.  Molecular analysis indicated CCCI may be more likely to occur in patients colonized or 
infected with MRSA strains typically associated with hospital-associated infections. We 
recognized patients who may benefit from additional resources for infection prevention and control 
in the hospital to prevent acquisition of an emerging MDRO through multiple organism 
colonization or infection. 
MDRO environmental contamination facilitates MDRO transmission. In chapter three, we 
identified a hospitalized patient type colonized with MDRO more likely to contaminate their 
 xi 
environment. Using latent class analysis, we categorized patients into two classes based on 
mechanical ventilation status, consciousness status at admission and requiring assistance with 
activities of daily living prior to admission. Low functional status patients were more likely to 
contaminate their environment. Infection prevention practices, such as hygiene assistance, 
enhanced environmental disinfection and contact precautions may contribute to reducing the 
burden of environmental contamination by these patients. 
 Chapter four includes a surveillance study of environmental contamination in a child care 
center with the goal of guiding environmental cleaning and disinfection practices. We 
demonstrated the feasibility of longitudinal surveillance of a variety of fomites to detect overall 
contamination and the frequency of contamination with MDRO and viral pathogens. Water-
associated sites were identified as harboring a higher bioburden and being contaminated more 
frequently with pathogens, demonstrating the potential of water to act as a reservoir for 
microorganisms and distribute them in the environment. We detected a higher bioburden on 
objects with irregular surfaces or which were cleaned less frequently. Child care providers should 
consider the ability to decontaminate a surface balanced against the development of children when 
including items in the classroom. 
 Chapter five examines the knowledge added from this research and the public health 
implications related to our findings. Support for current infection prevention and control 
recommendations are addressed and additional strategies for interventions are considered. 
Potential future research directions informed by findings in this dissertation, including 
investigations into mechanisms of acquisition and transmission and potential interventions to 
interrupt these processes are discussed.  
 xii 
 In the appendix, I present a proposal for a future research project to develop a self-screening 
method for VRE. While this may have multiple applications, my goal is to use this in community-
based studies, where VRE is prevalent but under-investigated. Better surveillance of VRE in the 
community will inform best practices for prevention of transmission and acquisition in this setting, 
while also guiding future research regarding VRE in community.  
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Chapter 1:  Introduction 
 
1.1: Antibiotic Resistance 
The United Nations’ (UN) Interagency Coordination Group on Antimicrobial Resistance 
describes antimicrobial resistance as a global crisis that jeopardizes the worldwide effort to achieve 
the UN Sustainable Development Goals.1 A report commissioned by the United Kingdom 
Government and Wellcome Trust estimated 700,000 global deaths per year from antimicrobial 
resistance disease and predicts a continued rise in resistance will result in 10 million deaths 
annually and cost up to $100 trillion by 2050.2 The Infectious Disease Society of America 
estimated infections from antimicrobial-resistant organisms cause $21-$34 billion in healthcare 
costs and 8 million additional hospital days annually in the U.S.3 
Antimicrobial resistance is prevalent among all groups of infectious organisms. Antifungal 
resistance is an emerging problem worldwide. Four classes of antifungals are primarily used to 
treat fungal infections, azoles, polyenes, pyrimidine analogs and echinocandins. Resistance to any 
of these drugs would reduce an already limited pool of treatment options. Clinical laboratories 
often do not have the capabilities to test for antifungal resistance, which can result in 
underdiagnosis and treatment failures.4 Resistance to antifungals has been observed among 
numerous genera, with antifungal resistance among Candida and Aspergillus presenting a major 
challenge due to their prevalence.4–7 
Antifungal-resistant Candida spp. are of particular concern. Drug-resistant C. auris has 
been labeled an urgent threat by the Centers for Disease Control and Prevention (CDC); a 318% 
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increase in drug-resistant C. auris cases in the U.S. was observed in 2018 compared to the average 
number of cases from 2015-2017.4 Pan-resistant C. auris isolates have emerged worldwide.8,9 
Resistance to antifungals may result in worse health outcomes. Investigators identified 51 cases of 
C. auris infections in New York City, including 50 resistant to at least one antifungal, during a 
retrospective review of cases from May 2013 to April 2017.10 Of these 51 patients, 23 (45%) died 
within 90 days, although deaths attributable to C. auris were unknown. Other species of drug-
resistant Candida are also a concern, causing an estimated 34,800 infections and 1,700 deaths in 
the U.S. in 2017.4 Approximately 7% of bloodstream infections with Candida spp. are resistant to 
antifungals, with resistance to fluconazole in 8.6% of C. glabrata isolates and 7.7% of C. 
parapsilosis isolates.11  
Aspergillius spp. are the other major emerging drug-resistant threat among fungi.4 
Aspergillus infections are treated primarily with azoles and resistance to these antifungals is 
developing which can worsen health outcomes. Investigators detected 37/196 (19%) aspergillus 
isolates from invasive infections were resistant to azoles in a five-year retrospective study at three 
tertiary care facilities in the Netherlands.12 Patients with resistant strains had significantly higher 
mortality than patients with susceptible strains on day 42 (49% vs 28%; P = .017) and on day 90 
(62% vs 37%; P = .0038). Although less common in the U.S., drug-resistant Aspergillus has been 
observed, with 10/274 (3.6%) resistant to azoles and 18/274 (6.6%) resistant to amphotericin B in 
isolates collected from the Transplant-Associated Infection Surveillance Network from 2001 to 
2006.13 The emergence of antifungal resistance among Candida and Aspergillus and the presence 
of resistance among other genera of fungi demonstrate the potential for antifungal resistance to 
become a problem for healthcare providers and worsen health outcomes for patients.Antimicrobial 
resistance is present among viruses as well, causing treatment challenges for infections caused by 
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these pathogens. Identifying antiviral resistance can be difficult. Phenotypic testing can determine 
antiviral susceptibility but is time consuming and costly. Genotypic testing can be performed 
quickly but may rely on known mutations causing resistance; novel mutations or a lack of known 
resistance mutations may limit the detection of antiviral resistance, especially without phenotypic 
information.  
As antiviral resistance increases among viruses causing both acute and chronic infections, 
identifying resistant pathogens is important for determining treatment options. Influenza, a 
common cause of acute respiratory infections, has demonstrated resistance to anvirials. 
Adamantanes, which had been previously used to treat influenza A infections, are no longer 
recommended for treatment due to high levels of resistance (>99% for influenza A(H3N2) and 
influenza A(H1N1)pdm09 in the U.S.).14 Neuraminidase and endonuclease inhibitors are 
recommended by the CDC for treatment of both influenza A and B infections; resistance to these 
antivirals is present in less than 1% of isolates tested by the CDC in the 2019-2020 influenza 
season.14 With one class of antiviral no longer used to treat influenza and resistance observed to 
the other antiviral class primarily used to treat this virus, the potential exists for continued antiviral-
resistance to emerge among influenza, further reducing treatment options of these infections. 
Antiviral resistance is present in among viruses causing chronic infections, posing a 
different challenge as antivirals are often used for long-term management of chronic infections. 
Human immunodeficiency viruses (HIV) have a propensity to be error prone during replication 
and are highly variable..15,16 These variations result in treatment failures with single agents, 
necessitating the use of combination antiretroviral therapy. For hepatitis B infections, antiviral 
resistance develops in >70% of patients receiving lamivudine.17 Hepatitis B resistance to other 
antivirals is low (less than 2% in patients with long term treatment using entecavir), but resistance 
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is detected in higher proportions of patients treated with entecavir following lamivudine treatment 
failure (>50% after five years of treatment), indicating cross-resistance can occur at a high rate.18 
Resistance to nucleoside analogues has been observed among herpesviruses. For herpes simplex 
viruses, resistance is low for immunocompetent patients (<1.0%) but is more common for 
immunocompromised patients (3.5%-10%).19–26 Prolonged use of nucleoside analogues results in 
increased risk of antiviral resistance in herpesvirus infections.27 The prolonged use of antivirals in 
chronic infections allows for the development of resistance over time, complicating the treatment 
of these pathogens. 
Antibiotic-resistant bacteria also contribute substantially to the burden of antimicrobial 
resistance disease. Based on national reports, the World Health Organization (WHO) noted 
antibiotic resistance in ≥50% of isolates among bacteria commonly causing infections in 
hospitalized patientsand the community including 1) Klebsiella pneumoniae resistant 3rd 
generation cephalosporins in all six WHO regions, 2) Escherichia coli resistant to 3rd generation 
cephalosporins, E. coli resistant to fluoroquinolones and methicillin-resistant Staphylococcus 
aureus (MRSA) in five of six WHO regions and 3) Klebsiella pneumoniae resistant to 
carbapenems in two out of six WHO regions.28 Antibiotic resistance was reported in ≥25% of 
isolates commonly causing infections in the community including 1) Streptococcus pneumoniae 
non-susceptible or resistant to penicillin in all six WHO regions, 2) nontyphoidal Salmonella 
resistant to fluoroquinolones and Neisseria gonorrhoeae resistant to 3rd generation cephalosporins 
in three out of six WHO regions and 3) Shigella species resistant to fluoroquinolones in two out 
of six regions.28 In the U.S. more than 2.8 million antibiotic-resistant infections occur annually 
resulting in 35,000 deaths.4 The prevalence of infections with antibiotic-resistant bacteria is 
especially problematic due to difficulties in treating these infections, resulting in higher morbidity 
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and mortality compared to susceptible bacteria.29–31 Antibiotic resistant infections also increase 
healthcare costs through longer lengths of hospital stays, the necessity of treating morbidity 
resulting from infections and use of expensive antibiotics.32,33 
Much of the focus of antibiotic-resistant infections lies in healthcare settings due to their 
prevalence and impact on patient health outcomes. Among eight of the most common bacterial 
pathogens that caused healthcare-associated infections (HAI) in the U.S. from 2015-2017, seven 
demonstrated greater than 20% non-susceptibility to at least one class of antibiotics in device-
associated infections, including S. aureus, P. aeruginosa and Acinetobacter spp., and four in 
surgical-site infections, including E. coli and Enterococcus faecium.34 Risk factors for antibiotic-
resistant bacteria colonization and infection, such as antibiotic use, presence of indwelling devices 
and increased duration of hospital stay, are commonly found among hospitalized patients, 
especially critically ill patients.35–37 Furthermore, shared environments and healthcare workers 
(HCW) can become contaminated and provide indirect transmission routes for pathogens between 
patients.38–42 The combination of these factors create an environment where the prevalence of 
multidrug-resistant organisms (MDRO), defined as non-susceptibility to at least one antimicrobial 
agent in at least three different antimicrobial classes, in hospitals is high and mechanisms to 
transmit MDRO between at risk patients exist, including routes without direct contact between 
patients.43 A cycle forms of patients acquiring MDRO and contaminating both the environment 
and HCW resulting in transmission of MDRO to other patients. Patients with newly acquired 
MDRO then begin the cycle again. Due to the morbidity and mortality associated with MDRO and 
their limited treatment options because of antibiotic-resistance, these patterns of transmission and 
acquisition in hospitals require interventions to improve health outcomes for patients.  
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Antibiotic-resistant bacteria in community settings receive less attention but likewise 
contribute to the overall burden of adverse health outcomes resulting from these organisms. Some 
pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum 
β-lactamase (ESBL)-producing Enterobacteriaceae, transitioned from being primarily nosocomial 
pathogens to being prevalent in the community as well.44,45 Emergence in the community may 
occur for multiple reasons. In the case of MRSA, a novel staphylococcal cassette chromosome was 
identified in community strains, suggesting resistance was newly acquired in the community and 
not directly related to strains causing HAI.46,47 The potential also exists for MDRO carriers in 
healthcare settings to introduce MDRO into the community. Calfee et al. conducted an 
investigation of MRSA transmission between 88 discharged patients with hospital-acquired 
MRSA and both 130 of their close contacts (spouse, parent, child or caregiver) and 42 of their 
casual contacts (friends, siblings or roommates).48 Screening of the personal contacts revealed 24 
(18.5%) close contacts and 1 (2.4%) casual contact were positive for MRSA. Pulsed-field gel 
electrophoresis (PFGE) was performed on MRSA isolates from 9 index patients and 11 contacts. 
Isolates from contacts for eight out the nine index patients were identical to those recovered from 
the index patient. This study demonstrates the potential for MDRO introduction from healthcare 
facilities into the community, leading to further spread outside healthcare facilities. 
Some resistant bacteria are still considered to be primarily hospital-acquired pathogens and 
receive little attention in the community, such as vancomycin-resistant enterococcus (VRE). 
However, some small, community based studies have observed VRE colonization prevalence to 
range from 5-38%, indicating their presence in the community may be greater than previously 
thought.49–54 Carriers of MDRO in the community may introduce these pathogens during 
healthcare admissions. Denkinger et al. conducted a 12-year study at a single tertiary care facility 
 7 
including both infection and surveillance samples.55 During that time, there were an average of 
39,197 admissions per year (range 36,733–42,262) with an average of 7534 positive bacterial 
cultures per year (range 5541–8726). The researchers observed a significant increase in the 
prevalence of VRE, multidrug-resistant gram-negative (MDRGN) and MRSA at admission in 
patients <65 years old and a significant increase in VRE and MDRGN in patients at admission ≥65 
years old.55 The proportion of Enterococcus, gram-negative and S. aureus isolates detected at 
admission with resistance to antibiotics increased significantly as well for patients ≥65 years old. 
This study suggests MDRO prevalence in the community could be increasing and that community 
carriers of MDRO may provide a means of introducing MDRO into healthcare facilities. The 
potential for a cycle of transmission of antibiotic-resistant bacteria between community and 
hospital settings exists and addressing these problems could provide substantial relief to the burden 
posed by antimicrobial-resistant organisms. 
Combatting the global antibiotic-resistance crisis first requires an understanding of the 
development of antibiotic resistance. Bacteria acquire resistance genes through mutations during 
replication or horizontal gene transfer from other bacteria, both of which have been demonstrated 
in vitro.56,57 Antibiotics kill susceptible organisms, leaving resistant bacteria to grow and spread. 
With each newly developed antibiotic, resistant organisms arise, limiting the utility of these 
drugs.58 This cycle of drug development and resistance has been exacerbated in recent decades by 
the dearth of development of new antibiotic classes.28 Additionally, the combination of resistance 
acquisition methods and selective pressures from antibiotic use have resulted in the emergence of 
MDRO, which have few or no treatment options.28,43,59,60 These treatment challenges force the 
development of other strategies to prevent infections with antibiotic-resistant bacteria. 
Determining patients at risk for MDRO acquisition guides infection prevention and control 
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policies. The role of multiple organism colonization and infection in MDRO acquisition will be 
investigated in this context. 
1.2: Multiple Organism Colonization and Infection 
Multiple organism infections present a variety of challenges to clinicians and researchers. 
Surveillance of these infections demonstrates that multiple organism infections are present with 
considerable prevalence in hospital settings. Royo-Cebrecos et al. observed 194 (10.2%) of all 
bloodstream infections in cancer patients at a university hospital in Spain over ten years to be 
caused by multiple organisms.61 Escherichia coli (33.8%) and Enterococcus spp. (30.6%) were 
the most common organisms identified in the multiple organism infections. MDRO were 
significantly more likely (20.6% vs 12.9%; p = 0.003) to be cultured in multiple organism 
infections. During a six-year study of military personnel with deployment-related traumatic 
injuries at Walter Reed National Military Medical Center, Heitkamp et al. reported 259 (66.1%) 
of 392 patients with a at least one wound infection and a positive culture had multiple organism 
infections.62 Patients with Enterococcus spp. in their wounds were significantly more likely to 
have multiple organism infections (n=141; 91.0% vs. n=118; 49.8%; p<0.001). Ferrer et al. 
investigated pneumonia acquired in the intensive care unit (ICU) over nine years at a university 
hospital in Spain, reporting 41/215 (16.0%) were caused by multiple organism.63 S. aureus (41.4%) 
was the most commonly identified organism in multiple organism pneumonia. In addition to their 
propensity to be detected in multiple organism infections, S. aureus and Enterococcus have been 
frequently identified together in hospitalized patients. In an eight-month prospective study by 
investigators at Cleveland Veterans Affairs Medical Center, 23 (62%) of 37 patients with VRE 
intestinal colonization were also colonized with intestinal S. aureus, including 20 (54%) with 
MRSA.64 The prevalence of multiple organism colonization and infection has prompted further 
 9 
research regarding the health outcomes of these infections. While this research may focus on 
outcomes such as morbidity and mortality, multiple organism colonization and infection may result 
in other outcomes, such as the development of additional resistance phenotypes. 
1.3: Multiple Organism Infection and Vancomycin-Resistant Staphylococcus aureus 
One unique situation regarding multiple organism colonization and infection is the 
development of vancomycin-resistant S. aureus (VRSA) during cases of co-colonization or 
coinfection (CCCI) with MRSA and VRE. VRSA is an emerging pathogen worldwide.65–74 The 
acquisition of vancomycin resistance has been hypothesized to occur during CCCI with MRSA 
and VRE through horizontal gene transfer.57 Preventing MRSA and VRE CCCI may prevent the 
future emergence of VRSA. MRSA and VRE are two of the most common pathogens causing HAI 
and are also commonly found contaminating the hospital environment and the hands of patients 
and HCW.34,75,76  The prevalence of MRSA and VRE in hospitals suggests hospitalized patients 
may have an increased risk of exposure to these organisms.34 Identifying patients at risk for MRSA 
and VRE CCCI can aid in developing infection prevention strategies to prevent CCCI and, 
potentially, VRSA acquisition. Previous research on MRSA and VRE CCCI has been limited by 
sample size, exclusion of patient types, restriction of Enterococcus species and a lack of molecular 
analysis of pathogens. The objective of aim 1 was to identify risk factors for MRSA and VRE 
CCCI to prevent future co-acquisition in hospitalized patients. Furthermore, a molecular analysis 
of pathogens was performed to detect associations between characteristics of MRSA and VRE and 
their likelihood of co-existing in a host. Molecular markers and strain types may provide 
information such as identifying isolates associated with HAI which could aid in determining how 
CCCI occurs. 
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1.4: MDRO Environmental Contamination in Hospitals 
Infection prevention and control strategies can be directed toward individuals at risk for 
MDRO acquisition. Interrupting pathogen transmission is a primary area of focus of infection 
prevention in hospitals. Bacteria can be transmitted through a variety of routes, providing many 
potential points of intervention. Of these transmission modes, MDRO contamination of fomites, 
both in hospital and community settings, will be explored here.  
MDRO can be carried by asymptomatic and symptomatic individuals and are shed into the 
environment by both host types from multiple body sites, including in respiratory secretions and 
fecal matter, contributing to the transmission of these pathogens.40,77–79 Shedding can result in 
environmental contamination and subsequent MDRO transmission through direct environmental 
contact or contact with individuals contaminated by the environment.80–82 Carriers can shed 
MDRO for months or years, creating a long-term risk of pathogen transmission by unwitting 
hosts.83–85 MDRO viability on surfaces adds to the risk of transmission through the environment. 
Wagenvoort et al. used MRSA clinical isolates to inoculate glass bottles. These isolates survived 
between 225 and 318 at temperatures between 20°C and 22°C and humidity ranging from 24-47% 
during the study period.86 Wendt et al. inoculated polyvinyl chloride with VRE. Strains survived 
for up to four months.87 Temperature during the study was 22°C±2 and humidity was 50%±5. 
Long survival times of MDRO in the environment can create reservoirs facilitating transmission. 
 Environmental contamination has been implicated in the transmission of MDRO in 
hospitals. MDRO have been isolated from environmental surfaces repeatedly in patient 
rooms.79,88,89 For transmission of MDRO to occur from one patient to another through the 
environment, several steps are required. First, an MDRO carrier must shed the organism into the 
environment, such as through direct contact with the environment by colonized skin or by 
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excreting contaminated bodily fluids. Wilson et al. identified 52 patients colonized with MRSA in 
ICUs of two London, England hospitals.90 In 34 cases, the patient room environment was 
subsequently contaminated by a strain similar to that in the colonized patient, identified by phage 
typing, which was not present prior to the patient occupying the room. This study demonstrates 
the potential for a patient to directly contaminate the hospital environment. 
Once in the environment, MDRO must be transferred to other patients. One mechanism of 
transmission may be through a vector, such as a HCW. Wilson et al. observed 120/585 (20.5%)  
patient and HCW interactions resulted in MDRO contamination of gloves and gowns.38 PFGE was 
performed for isolates from 22 of these interactions; 18 HCW had strains related to patients and 
20 had strains related to the environment, displaying the ability for MDRO transfer to HCW to 
occur. HCW workers who are carriers of MDRO can then transmit these pathogens to patients. 
Bertin et al. documented a MRSA outbreak among 37 neonates in a neonatal ICU caused by direct 
care of a HCW infected with the outbreak strain, confirmed by repetitive sequence PCR.91 The 
outbreak began two months after the HCW started in the unit and no new cases were detected in 
the year following the HCW leaving the unit. Direct care from HCW can facilitate inoculation of 
the MDRO in a patient, which is required for colonization or infection. 
Patients can also have direct contact with contaminated environments. Transfer of the 
MDRO through this contact and subsequent self-inoculation would be required for MDRO 
colonization or infection. Prior residence in a hospital room by an MDRO carrier can result in 
environmental contamination which can lead to transmission of MDRO through patient contact. 
Creamer et al. identified 92/929 (10%) of patients screened in two medical and two surgical wards 
at a tertiary hospital during two six-week periods were positive for MRSA.42 Using 
epidemiological investigations and PFGE for isolate typing, they determined the source of eleven 
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MRSA transmission events among patients residing in the same ward bay within three weeks of 
each other. In six events, only patients were the source, in three cases, patients and the environment 
were the source, and in two cases, the environment was the source.42 This study illustrates the 
potential of MDRO transmission to occur through the environment.  
Other studies have identified prior room occupancy with an MDRO carrier increases the 
risk MDRO acquisition for subsequent inpatients residing in the same room, indicating MDRO 
contamination of the environment could affect patient outcomes.92–94 While demonstrating direct 
transmission and acquisition of MDRO through the environment is not feasible experimentally, 
these studies reveal the mechanisms required for transmission to occur are possible. The variety 
of MDRO transmission routes in the environment demonstrate its viability as a focus for infection 
prevention and control actions such as environmental decontamination. 
 Several points of intervention have been targeted to reduce MDRO transmission and 
acquisition in healthcare facilities. Hand hygiene and contact precautions are important tools to 
prevent MDRO transmission but HCW are not always compliant and these methods of prevention 
do not address contamination in the patient’s room from prior occupants.92–95 Environmental 
decontamination has been shown to be effective at reducing the burden of MDRO infections in 
hospitals, especially when part of a broader effort.96–98 High compliance with these practices can 
be effective at reducing the impact of environmental contamination, but compliance is time-
consuming and logistically difficult and can often be sub-optimal.99–101 Automated cleaning 
options are designed to cover all surfaces in a room, but are more expensive and are not always 
more effective than manual cleaning methods.102 Further complicating disinfection practices, 
evidence suggests MDRO are developing resistance to commonly used cleaning agents.103,104 
These challenges influence decision making regarding environmental disinfection and require 
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efficient use of limited resources directed toward interventions which would have the greatest 
impact. 
1.5: Risk Factors for Environmental Contamination by MDRO Carriers 
Identification of patients at risk of contaminating their environment can aid in guiding 
resource allocation for environmental disinfection. Patients with MDRO infections may be 
identified through the course of clinical care. However, asymptomatic MDRO carriers may go 
unnoticed without screening. Numerous studies have identified risk factors of MDRO colonization 
in hospitalized patients who could all potentially shed MDRO into the environment..105–108 
However, determining if specific patient characteristics increase the risk of contaminating the 
environment has received less attention.82,109–111  
Research determining who contaminates their surrounding environment in hospitals has 
been approached from several perspectives. Investigators have quantified the burden of shedding, 
by determining the bacterial load at the screening site or in bodily fluids, with the goal of detecting 
associations with contamination.109,111 These studies aim to understand the role the amount of 
bacteria present in  or on a host may have in environmental contamination. Other research have 
examined if the presence of MDRO on the body, including hand contamination and number of 
body sites colonized, is associated with contamination.82,110 This research demonstrates MDRO 
presence on the skin, which interacts with the environment through physical contact, provides a 
mechanism for contamination by patients. Investigators have also explored other routes for MDRO 
to contaminate the environment. MDRO detected in bodily fluids, including diarrhea and urine, 
could result in MDRO excreted from the body into the environment without skin contact and have 
been examined in relation to contamination.109,111,112 Wounds may present another route of 
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contamination, either transmitting MDRO to the environment through direct contact or by fluid 
secretions, and have been implicated in environmental transmission.112 
Prior investigations  have been limited regarding patient characteristics which may 
influence behaviors, such as how they physically interact with the environment, their ability to 
maintain personal hygiene or coughing during respiratory illness, which could facilitate 
environmental contamination by a patient. Other factors such as the presence of indwelling devices 
or incontinence could provide routes for MDRO excretion from the body. Factors influencing the 
bacterial load during shedding, including antibiotic use, may influence contamination as well.113,114 
With the potential for many variables to impact environmental contamination by a patient, an 
investigation of the association between patient characteristics and contamination would be 
worthwhile. Characteristics that can be determined during standard clinical care may aid in 
detecting patients more likely to contaminate their environment without additional testing. 
Identifying these factors may also elucidate mechanisms for contamination, allowing for the 
development of infection prevention strategies. The objective of aim 2 was to use patient 
characteristics to identify a patient type more likely to contaminate their environment with the goal 
of aiding resource allocation for environmental decontamination and infection prevention in 
hospitals. 
1.6: MDRO in Young Children 
Children are an understudied population with regards to MDRO, especially in community 
settings. However, evidence suggests this is a growing problem, as exemplified with MRSA. 
Investigators in Argentina reported 45% (99/221) of pediatric, community-associated (CA) S. 
aureus pneumonia from three children’s hospitals during 2007-2008 were caused by MRSA, a 
significant increase over the prior two years.115 The median age for CA-MRSA infections was 6.1 
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years old. The rate and prevalence of these infections increased significantly compared to the prior 
two years. Purcell and Fergie conducted fourteen-year study at Driscoll Children’s hospital and 
identified 1002 pediatric infections with MRSA, 92.6% being CA-MRSA.116 The proportion of all 
S. aureus isolates that were methicillin-resistant increased from 2.9%-10.6% in the first 10 years 
of the study and dramatically increased in the final four years, ranging from 19.0%-62.4%. These 
studies coincided with the emergence of CA-MRSA, which began in the late 1990’s in the U.S., 
with the USA300 strain becoming the dominant strain in the community.117 The increase in CA-
MRSA among children in these studies demonstrates that young children were not exempt from 
the overall emergence of CA-MRSA.  
 Extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae present another 
developing problem in the community. Dayan et al. conducted a six-year study at a secondary-care 
Israeli medical center and identified 37 pediatric cases of CA-urinary tract infections (UTI) caused 
by ESBL producers (3.2% of all CA-UTI).118 A significant increase in the proportion of ESBL-
producing isolates was observed during the study (1.2% in year one vs. 5.8% in year six; p for 
trend=0.28). Zhu et al. identified 111 cases of ESBL-producers causing community acquired-UTI 
at Children’s Hospital of Michigan over a five-year period, with a median age of four years old.119 
These studies demonstrate the potential burden of infections caused by ESBL-producers in the 
community, including for young children. Finding targets for intervention to disrupt MDRO 
acquisition by children in the community will help alleviate MDRO emergence in this population. 
1.7: MDRO Environmental Contamination in Child Care 
 Child care centers provide a setting for pathogen transmission between children, 
where attendees are in close contact and share environments. Young children also display 
behaviors which may facilitate pathogen transmission, such as interacting with the environment 
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with their hands and mouthing of fomites. Child care attendees who carry MDRO may transmit 
these pathogens through direct contact with other children or through contamination of their 
environment. Stoesser et al. detected ESBL-producers in 92 (23%) screened children from 12 child 
care centers in Laos.120 In several recent screening studies of child care attendees, MRSA was 
detected in 0.53%-7.4% of children.121–124 In one of these studies, seven children (6.7%), one 
employee (3.1%), six household members of attendees and employees (35%) and four 
environmental samples (2.0%) screened positive for MRSA in a North Carolina child care 
center.123 Ten isolates, one from an employee, three from the employee’s child, two from 
attendees, and four from environmental sites were indistinguishable or highly similar by  
DiversiLab microbial genotyping system for strain typing. Three other isolates from two children 
were similar to each other and were different from all other isolates. These highly related isolates 
demonstrate the potential for transmission within the child care center, including through the 
environment, and within households of attendees and employees. Infection control programs 
including environmental cleaning and disinfection have reduced illnesses among child care 
attendees.125,126 National recommendations for environmental decontamination, provided through 
a joint effort by the American Academy of Pediatrics, the American Public Health Association, 
and the National Resource Center for Health and Safety in Child Care and Early Education, are 
comprehensive.127 However, local regulatory agencies may be the primary source for cleaning and 
disinfection regulations. In Michigan, the Licensing and Regulatory Affairs (LARA) branch of the 
Michigan state government regulates CCC’s and provides these guidelines, which are less 
comprehensive than the national recommendations.128 LARA does not provide guidance for 
decontamination of many items such as toys, floors, toilets, cabinets or water tables. Inconsistent 
guidelines from these agencies can result in suboptimal compliance with best practices for 
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environmental decontamiantion.129 Staff of child care centers have other responsibilities including 
supervision, education, food preparation and child hygiene, which may limit time dedicated to 
cleaning and disinfection, impacting compliance as well.  
Surveillance of environmental contamination in CCC’s can guide environmental cleaning 
and disinfection policies when time and resources are limited. Much of the previously conducted 
research of environmental contamination in CCC’s assesses viral contamination.130–133 Other 
research has focused on fecal coliforms, although this may be of less relevance for centers with 
children aged out of diapers or when no outbreaks of diarrheal disease are present.134–141 Food 
preparation areas have also received attention from researchers, but these surfaces likely have 
limited contact with attendees.142,143 MDRO contamination surveillance in child care centers has 
been sparse.144 Longitudinal surveillance of CCC environments, sampling from a large variety of 
fomites and targeting a range of pathogens, including viral and antibiotic-resistant, would provide 
the best guidance for environmental cleaning and disinfection strategies in these settings. The 
objective of aim 3 was to characterize environmental sites with high bioburden and high frequency 
of contamination with antibiotic-resistant and viral pathogens in a CCC with preschool age 
children to direct infection prevention policies. We also aimed to demonstrate the feasibility of 
such a study for application in larger scale studies in the future. 
1.8: Specific Aims and Hypotheses 
The overarching objective of this dissertation is to investigate MDRO acquisition and 
transmission. First, the risk factors of MDRO acquisition in the context of multiple organism 
infections were investigated in aim 1. Secondly, mechanisms of MDRO transmission in the 
environment were explored in aims 2 and 3. We investigated who is at risk for contaminating the 
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environment in hospitals in aim 2. Finally, we examined patterns of MDRO contamination in the 
environment in child care. 
 
Aim 1: Characterize the epidemiology of co-colonization or coinfection (CCCI) with methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) among 
hospitalized patients. 
Sub-Aim 1: Identify clinical and demographic characteristics at the individual level that are 
risk factors of MRSA and VRE CCCI among hospitalized patients 
Hypothesis: Individual characteristics which were identified in previous MRSA and 
VRE CCCI studies, including prior hospitalizations, previous antibiotic use and the 
presence of indwelling medical devices, and those observed in prior VRSA 
infections, including diagnosis of diabetes, will be associated with MRSA and VRE 
CCCI. 
Sub-Aim 2: Identify the molecular characteristics of MRSA among hospitalized patients 
colonized or infected with MRSA that are risk factors of MRSA and VRE CCCI 
Hypothesis: Clonal complex 5 MRSA isolates and Panton-Valentine leukocidin-
negative MRSA isolates will also be associated with MRSA and VRE CCCI, 
reflecting the characteristics seen in previous VRSA infection isolates. 
Main Findings: Healthcare exposure was a risk factor for MRSA and VRE CCCI. Other 
previously identified MDRO risk factors were also risk factors for MRSA and VRE CCCI 




Aim 2: Identify characteristics among hospitalized MDRO colonized patients which allow for the 
classification of a type of MDRO carrier at increased risk for contaminating their environment. 
Hypothesis: Risk factors for environmental contamination by MDRO carriers will be 
similar to those for prolonged shedding including the presence of severe comorbidities, 
previous antibiotic use, the presence of indwelling medical devices and prior residence in 
long-term care facility. 
Main Findings: Patients with low functional status contaminated their environment more 
frequently than high functional status patients. 
 
Aim 3: Use longitudinal surveillance of the environment of a CCC for preschool aged children to 
characterize the bioburden on fomites and the frequency of contamination with MDRO and viral 
pathogens to identify points intervention for cleaning and disinfection practices. 
Hypothesis: Our study methodology will prove to be feasible for sampling the 
environment for overall bioburden and bacterial and viral pathogens. Fomites cleaned 
less frequently or thoroughly will be contaminated with a higher bioburden. These 
fomites will also be contaminated with viral and bacterial pathogens more frequently. 
Irregular surfaces or surfaces which may be damaged during cleaning or disinfection are 
fomite characteristics which limit the thoroughness of cleaning and disinfection. 
Main Findings: Sites where children washed and played with water were among the most 
contaminated. Additionally, sites that were difficult to clean or were cleaned less 
frequently were also among the most contaminated. 
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Chapter 2:  Epidemiology of Methicillin-Resistant Staphylococcus aureus and Vancomycin-
Resistant Enterococci Co-colonization and Coinfection 
2.1: Author Summary 
Vancomycin-resistant Staphylococcus aureus (VRSA) is likely preceded by co-
colonization or coinfection (CCCI) with methicillin-resistant Staphylococcus aureus (MRSA) 
and vancomycin-resistant enterococci (VRE). We identified admission from another healthcare 
facility to be a risk factor for MRSA and VRE CCCI in two of our three primary analyses, 
suggesting healthcare exposure is a risk factor for the acquisition pathogens of concurrently. We 
also observed patients with Panton-Valentine leukocidin-negative MRSA isolates and clonal 
complex 5 MRSA isolates to have an increased risk of MRSA and VRE CCCI. These isolates are 
typically associated with healthcare-associated infections, providing further evidence healthcare 
exposure is a risk factor for CCCI. 
2.2: Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
enterococci (VRE) are common in healthcare settings. MRSA resistance to vancomycin, a first-
line treatment, can independently arise through horizontal gene transfer with VRE and may arise 
independently in individuals co-colonized or coinfected with both organisms. The objective of this 
study was to identify risk factors for MRSA and VRE co-colonization or coinfection (CCCI) 
among hospitalized adults. 
A 1:1 matched case control study was conducted at the five Detroit Medical Center 
inpatient hospitals from January 2012 to April 2016. Cases were prospectively identified and 
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obtained from hospitalized CCCI patients and compared to three separate inpatient control groups: 
1) MRSA infection only 2) VRE infection only and 3) inpatients without MRSA or VRE. We used 
multivariable logistic regression to evaluate risk factors for CCCI. 
A total of 134 CCCI cases, 109 MRSA controls, 88 VRE controls and 99 controls without 
MRSA or VRE were included in the analysis. Admission from another healthcare facility was 
significantly associated with CCCI in comparisons with MRSA controls [OR = 3.09 (1.45, 6.61)] 
and controls without MRSA or VRE [OR = 3.80 (1.62, 8.94)]. When restricting to cases and 
MRSA-only controls, carriers of either Panton-Valentine leukocidin-negative MRSA isolates [OR 
= 0.09 (0.01, 0.74)] or clonal complex 5 isolates [OR = 5.61 (1.49, 21.15)] were more likely to be 
co-colonized or co-infected with VRE. 
Admission from either a long-term care facility or another hospital was found to be a risk 
factor for CCCI, suggesting that healthcare exposures, a known risk factor of antibiotic-resistant 
bacteria acquisition, may increase the risk of CCCI. Targeted interventions aimed at this high-risk 
population may aid infection prevention and control efforts surrounding CCCI and VRSA. 
2.3: Introduction 
Vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus 
(MRSA) are among the most common healthcare-associated antibiotic resistant pathogens 145. 
Vancomycin is a first-line treatment for MRSA infections and the development of vancomycin 
resistance in MRSA further complicates treatment for this pathogen. The first case of vancomycin-
resistant S. aureus (VRSA) infection occurred in southeast Michigan in 2002, and eight of the 
fourteen U.S. cases have been identified in this region.65,146,147 VRSA has also been identified 
worldwide in clinical isolates from Brazil, Portugal, India, Iran.67–69,72 
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One proposed mechanism for the acquisition of vancomycin resistance by S. aureus, which 
has been demonstrated in vitro using E. faecalis, involves the conjugative transfer of a vancomycin 
resistance gene complex from a VRE donor to a MRSA recipient, requiring carriage of both 
organisms in the same host.147–149 In the U.S., no documented person-to-person transmission 
events of VRSA have occurred.65,147,148 The first seven VRSA cases occurred in individuals with 
a history of MRSA and Enterococcus (including four VRE) infection or colonization and VRE 
was recovered from ten of the fourteen U.S. VRSA cases.65,147,148 Sequencing of the twelve isolates 
from the first eleven VRSA cases indicated these isolates were independently acquired.150 
Sequencing demonstrated the first thirteen U.S. VRSA cases arose from MRSA parent 
lineages.65,147,150 The totality of this evidence supports the hypothesis that co-colonization or 
coinfection (CCCI) with MRSA and VRE is likely to precede VRSA infections. Knowledge of the 
epidemiology of CCCI would provide insight into key populations for interventions to prevent the 
further emergence and dissemination of VRSA. 
Several studies have investigated risk factors for CCCI but are hampered by small sample 
sizes and inconsistencies in study populations which limit generalizability and comparability.151–
158 In this study, we compare a single case group to multiple comparison groups to investigate the 
various unique pathways through which CCCI may arise. An investigation of MRSA and VRE 
molecular characteristics as potential CCCI risk factors, including those identified in patients with 
VRSA infections, was conducted to further enhance knowledge of the relationship between CCCI 




2.4.1: Study Design and Participants 
Data were obtained from a prospective, case control study which included individuals, at 
least 18 years of age, who received clinical care at one of the five Detroit Medical Center (DMC) 
inpatient facilities from January 2012 to April 2016. Eligible cases were prospectively identified 
and defined as hospitalized patients with clinical identification of MRSA and VRE isolated from 
infected body sites within seven days of one another. Individuals may become co-colonized or 
coinfected through three pathways, by acquiring either organism first with a subsequent acquisition 
of the second organism or by acquiring both organisms simultaneously. With this process in mind, 
cases were matched 1:1 with a control from each of three groups. Control group 1 included 
admitted individuals with MRSA infection only. Control group 2 included admitted patients with 
VRE infection only. These controls were matched to cases by admitting hospital, hospital unit at 
time of culture, index infection site and hospital length of stay at time of culture (</≥ 72 hours); 
the last criterion was subsequently relaxed during the study period to increase the number of 
eligible VRE controls. Control group 3 included admitted patients without MRSA or VRE 
infection, matched to cases by admitting hospital, unit at time of culture and hospital length of stay 
(control length of stay must have been no less than 48 hours shorter than the case length of stay at 
the time of the index culture). Additionally, admission for uninfected controls must have occurred 
within one month of the index culture date for the case. All control groups could include 
individuals with methicillin-sensitive S. aureus or vancomycin-sensitive Enterococcus infections. 
2.4.2: Data Collection 
Data were abstracted from participants’ electronic medical records and included: 
demographic information (age, gender, race), medical history (comorbidities, antibiotic use, 
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procedure history, medication history, infection history, presence of indwelling devices, prior 
hospitalizations), admission information (length of stay, location of patient, level of consciousness 
at admission, residence prior to hospitalization), pathogen-related information (species 
identification, antibiotic susceptibility, date of culture), and variables necessary for the calculation 
of the Charlson comorbidity index score.160 
2.4.3: Culture Collection and Processing 
Cultures were obtained from all patients with a clinical suspicion of infection as assessed 
by the treating physician. All cultures were processed by the DMC clinical microbiology lab for 
organism identification and antibiotic susceptibility testing prior to delivery to the investigators 
for further analysis. Organisms were delivered on agar slants and were cultured onto tryptic soy 
agar (Neogen, Lansing, MI) at 37°C for 18-24 hours. Isolated colonies were used to create 1 
McFarland inoculums in at least 2 mL of normal saline (0.9%). 800 µL of the McFarland inoculum 
was stored with 200 µL of 50% glycerol (Thermo Fisher Scientific, Waltham, MA) at -80°C. 
2.4.4: Panton-Valentine Leukocidin (PVL) Identification 
PVL genes were identified by PCR for MRSA isolates utilizing the Luk-PV-1 and Luk-
PV-2 primers as previously described.161 PCR was performed using the ProFlex PCR system 
(Applied Biosystems, Foster City, CA). A PVL-positive MRSA control, AIS 2006061, was used 
to ensure PCR success.  
2.4.5: MRSA Multilocus Sequence Typing (MLST) 
PCR of all seven housekeeping genes (arcC, aroE, glp, gmk, pta, tpi and yqiL) used for 
MLST was performed for MRSA isolates using the protocol and primers as previously described 
by Enright et al. except for the tpi forward primer (tpif 5′-GCATTAGCAGATTTAGGCGT-3′) 
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described in a separate study from Witte et al.162,163 Sequencing was performed using Sanger 
sequencing at the University of Michigan Advanced Genomics Core. 
2.4.6: VRE Virulence Genes 
The presence of five VRE virulence genes, asa1, gelE, hyl, esp, and cylA, was investigated 
using a multiplex PCR.164 Three VRE isolates with known status of the genes of interest were used 
as controls. All amplicons were visualized with a 1.5% agarose electrophoresis gel made with 
agarose (Invitrogen, Carlsbad, CA) 1X Tris-acetate-EDTA (Promega, Madison WI) and SYBR 
Safe DNA gel stain (Invitrogen, Carlsbad, CA). 
2.4.7: Statistical Analysis 
Covariates included in the analysis were selected a priori based on previous 
studies.65,148,151–157,165 Unadjusted analysis comparing the case group with each control group was 
performed using conditional logistic regression. To identify risk factors of CCCI, three separate 
multivariable analyses, one with each control group, were implemented. All adjusted analyses 
were performed using conditional logistic regression with a stepwise, forward selection process 
(α≤0.05 for inclusion in the model). Two secondary multivariable risk factor analyses comparing 
cases and MRSA infected controls were performed to assess any association between CCCI and 
either MRSA isolate sequence type or PVL status. The distribution of VRE virulence genes was 
assessed among cases and VRE controls. For individuals with multiple isolates of a specific genus, 
only the earliest identified isolate was considered for analyses including molecular characteristics 
of the microorganisms. As physical contact is likely required for the transfer of vancomycin 
resistance genes from VRE to MRSA, two unadjusted sensitivity analyses using conditional 
logistic regression were performed. First, cases with MRSA and VRE identified on the same day 
were compared to matched controls. Secondly, cases with MRSA and VRE identified in the same 
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specimen were compared to matched controls. All statistical analyses were carried out using SAS 
version 9.4 (SAS Institute, Cary, NC) except for the construction of the forest plot which was 
carried out using the forestplot package in R version 3.5.1 (R Foundation for Statistical Computing, 
Vienna, Austria). 
2.5: Results 
Of the 152 CCCI patients identified during the study period, 134 had no missing data and 
were matched to at least one patient from one of the control groups eligible for matching. These 
cases were included in the analysis (Figure 2-1). For matching to these 134 cases, 120 eligible 
MRSA controls, 96 eligible VRE controls and 109 eligible controls without MRSA and VRE. 
Were identified. Controls from each group were later excluded resulting in  109 cases matched to 
MRSA controls, 88 cases matched to VRE controls and 99 cases matched to controls without 
MRSA or VRE (Figure 2-1). Overall, the study population was predominantly black (82.6%) and 
male (56.1%) with a median age of 60 (Table 2-1). 
2.5.1: Cases and MRSA-Only Controls 
Compared to MRSA controls, cases were more often admitted from another healthcare 
facility and more likely to have reduced consciousness on admission, at least one prior 
hospitalization in the past year, recent antibiotic exposure, an indwelling medical device and a 
history of chronic skin wounds (Table 2-1). In the adjusted analysis, admission from another 
healthcare facility, having a prior hospitalization in the past year, having an indwelling medical 
device at the time of organism isolation and a history of chronic skin wounds significantly 
increased the odds of CCCI (Figure 2-2). 
 PVL status of 57 pairs of cases and controls was determined. Among these pairs, 19.3% of 
cases and 43.9% of controls were PVL-positive. A restricted, multivariable analysis revealed that 
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the presence of PVL genes in MRSA isolates was significantly associated with reduced odds of 
CCCI (Table 2-2). 
Among the cases and MRSA controls included in the main analysis, the sequence types 
(ST) for 157 MRSA isolates were determined (Figure 2-3). Four sequence types (ST8, ST450, 
ST683 and ST770) belonged to clonal complex (CC) 8, four were members of CC5 (ST5, ST100, 
ST105 and ST1863) and the remaining two, ST30 and ST278, were singletons. Analysis of the 
relationship between MRSA isolate ST and CCCI was restricted to cases and controls carrying 
CC5 or CC8 isolates, resulting in 58 matched pairs (Figure 2-3). In a matched multivariable 
analysis restricted to these 58 pairs, CC5 MRSA isolates were associated with CCCI (Table 2-4). 
Of the 82 cases with MRSA and VRE isolated on the same day, 68 were matched to MRSA 
controls. All significant associations between patient characteristics and CCCI status in the main 
unadjusted analysis were also significant in this sensitivity analysis (Table 2-5). Fifty of 63 cases 
with MRSA and VRE isolated from the same specimen were matched to MRSA controls. Three 
of the six significant associations observed in the main unadjusted analysis were also identified 
in this sensitivity analysis. (Table 2-6). 
2.5.2: Cases and VRE-Only Controls 
Cases were more likely than VRE controls to have a prior hospitalization in the past year 
and a previous MRSA infection in the past year (Table 2-2). A previous MRSA infection in the 
past year was significantly associated with CCCI in the multivariable analysis (Figure 2-2).  
The status of asa1, gelE, and hyl was determined for 22 pairs of cases and VRE controls; 
esp, and cylA status was determined for 19 pairs (Table 2-7).  No isolates were positive for hyl 
while cylA was rare. A majority of isolates were positive for asa1 and gelE while esp was identified 
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in approximately one third of isolates. Due to small sample sizes, differences in the frequency of 
these genes between cases and controls was not assessed. 
Fifty-four of the 82 cases with MRSA and VRE identified on the same day were matched 
to VRE controls. No significant associations between the patient characteristics and CCCI were 
identified (Table 2-5). Among the 63 cases with MRSA and VRE isolated in the same specimen, 
42 were matched to VRE controls. No difference was identified between cases and controls across 
all other covariates (Table 2-6). 
2.5.3: Cases and Controls Without MRSA or VRE 
Cases were more likely than controls without MRSA or VRE to be admitted from another 
healthcare facility and to have at least one hospitalization in the prior year, recent antibiotic 
exposure, a MRSA infection in the past year, an indwelling medical device, renal insufficiency, a 
history of chronic skin wounds, steroid exposure in the past three months and a Charlson 
comorbidity index score of at least five (Table 2-2). In the adjusted model, admission from another 
healthcare facility, recent antibiotic exposure and diabetes significantly increased the odds of 
CCCI (Figure 2-2). 
Sixty-one of the 82 cases with MRSA and VRE isolated on the same day were matched to 
controls without MRSA or VRE. All significant associations observed in the main unadjusted 
analysis were also identified in this sensitivity analysis except for the association between Charlson 
comorbidity index score and CCCI status (Table 2-5). An additional significant association 
between race and CCCI status was also detected in this sensitivity analysis. Of the 63 cases with 
MRSA and VRE isolated in the same specimen, 45 were matched to controls without MRSA or 
VRE. All significant associations found in the main unadjusted analysis between the participant 
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characteristics and CCCI status were also observed in this sensitivity analysis excluding the 
association of renal insufficiency and CCCI status (Table 2-6). 
2.6: Discussion 
Our findings indicate healthcare exposure is a risk factor for MRSA and VRE CCCI. One 
potential risk factor for CCCI, admission from another healthcare facility, was identified among 
hospitalized patients when comparing CCCI patients to patients with MRSA only or those without 
MRSA or VRE. Furthermore, among persons colonized or infected with MRSA, those with PVL-
negative MRSA isolates and those with CC5 MRSA isolates are more likely to be co-colonized or 
coinfected with VRE, providing more support healthcare exposure is a CCCI risk factor. We also 
identified several other risk  for CCCI which have been observed in previous CCCI studies as well, 
including skin wounds, antibiotic use, indwelling devices, previous MRSA infection and 
diabetes.151–158  
CCCI may develop through multiple pathways, including sequential or simultaneous 
pathogen acquisition, which have largely not been compared in prior research but was addressed 
in our study by comparing our cases to three different control groups.151–157 Similar risk factors 
were observed when comparing cases with both MRSA controls and controls without MRSA and 
VRE. Admission from another healthcare facility was a risk factor in both groups. Diabetes was a 
risk factor for CCCI when comparing cases with controls without MRSA and VRE. Chronic skin 
wounds are common in diabetes patients and was a risk factor for CCCI when comparing cases 
with MRSA controls.166 When comparing cases to VRE controls, a previous MRSA infection in 
the past year was the only risk factor for CCCI. These patients were likely to receive antibiotics to 
treat their infection. Antibiotic use was a CCCI risk factor when comparing to controls without 
MRSA and VRE, demonstrating some similarity of risk factors between these groups.  
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 Individuals admitted to hospitals from other healthcare facilities may have exposure to 
MRSA and VRE as both organisms are among the most common healthcare associated 
pathogens.58 In their study of long-term care facility (LTCF) residents, Flannery et al. similarly 
compared CCCI individuals to three control groups.157 While they did not explore any association 
between prior residence and CCCI status, they found no association between long duration of 
LTCF stays (admissions longer than 90 days) and CCCI, although their investigation included just 
17 CCCI individuals.157 The presence of skin wounds and antibiotic exposure were identified as 
risk factors in two of their three analyses, supporting our findings.157 Both MRSA and VRE are 
commonly isolated from chronic skin wounds, providing a rationale for an association between 
these wounds and CCCI.167 
 LTCF may also serve as a reservoir for CCCI individuals. Flannery et al. observed a MRSA 
and VRE co-colonization incidence rate of 2.4/100 resident months in one LTCF.157 Researchers 
in a second LTCF study found the prevalence of MRSA and VRE co-colonization to be 8.7% 
among LTCF residents.158 Once admitted to the hospital, LTCF residents may be contributing to 
the burden of CCCI in hospitals, partially explaining the association with CCCI and admission 
from another healthcare facility. 
Our findings garner mixed support from previous literature. Similar to our findings, Warren 
et al. identified prior admission from an LTCF and prior hospitalizations as CCCI risk factors.151 
Han et al. also observed prior hospitalizations, as well as urinary catheterization, to be CCCI risk 
factors.154 Other studies also identified invasive medical devices as risk factors.153,156,158 Multiple 
studies found antibiotic use to be associated with CCCI, further supporting our results.152,155,158 
Heinze et al identified diabetes and wounds as risk factors for CCCI, providing additional support 
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for our findings. Diabetes was also present in 10 of the 14 U.S. VRSA cases, indicating a potential 
association with VRSA.65,165 
Our prospective study had other advantages over previous CCCI research: 1) a larger 
sample of CCCI participants 2) no restrictions on patient types 3) no restrictions on Enterococcus 
species and 4) pathogen molecular analysis. Inconsistencies between the CCCI risk factors 
identified in our study and those observed by other researchers, may be due to differing study 
populations. Variations in the types of patients (hospital-wide vs. ICU only) and the carrier status 
of MRSA and VRE among study participants may limit comparability across studies.151–156 
Additionally, our study included patients from five inpatient facilities and accounts for the multiple 
pathways by which a person might become co-colonized or coinfected with VRE and MRSA 
through the inclusion of analyses with multiple comparison groups. 
The majority of CCCI risk factor investigations have lacked molecular analyses. In our 
study, PVL-negative isolates were associated with CCCI. PVL-positive MRSA isolates have been 
associated with skin and soft tissue MRSA infections and community-associated MRSA 
strains.168,169 PVL genes have been markedly absent from VRSA clinical isolates including all 13 
U.S. isolates tested by Saravolatz et al. in 2012 and four of five isolates in two Iranian 
studies.71,159,170 Boan et al. have previously reported PVL-positive MRSA isolates to be associated 
with mono-microbial infections, providing further support that these isolates are less likely to be 
found cohabitating with VRE.171 In contrast, Shettigar et al. identified an association between PVL 
positivity and multiple organism infections in diabetic foot ulcers, although this association was 
only observed when other virulence factors were absent in the MRSA isolate.172 Further research 
is needed to determine the impact of PVL and other virulence factors regarding the risk for CCCI 
and VRSA.  
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Our analysis also identified an association between CC5 MRSA isolates and CCCI. Twelve  
isolates (including two from one individual) from the first eleven U.S. VRSA cases belonged to 
CC5, although CC8 S. aureus isolates with a fully vancomycin-resistant phenotype have been 
observed.67,147,150 CC5 MRSA isolates are associated with healthcare-associated infections while 
CC8 isolates are more often identified as community isolates.173 CC5 isolates are also associated 
with more severe disease but have not been observed to cause more persistent infections.174,175 
Coupled with the PVL analysis, these findings suggest CCCI may be more likely to occur among 
individuals carrying healthcare-associated MRSA strains. 
An additional consideration for MRSA and VRE CCCI is biofilm formation. Biofilms are 
polymicrobial communities which are a common cause of infections.176 Bacteria in biofilms 
engage in synergistic activities, through extracellular excretion of molecules or gene transfer 
(including antibiotic resistance genes), which could affect health outcomes, including affecting 
response to treatment.177–180 Resistance gene transfer in biofilms may have implications for VRSA 
development. Both MRSA and VRE are able to exist in biofilms and were both isolated from a 
nephrostomy tube biofilm along with VRSA in a U.S. VRSA case.181–183 In our study, 63 cases 
had MRSA and VRE isolated in the same specimen, indicating the potential for biofilm formation 
with both isolates. Biofilms are common in infections involving indwelling devices and chronic 
skin wounds.184,185  In our unadjusted analyses restricted to cases with MRSA and VRE isolated 
in the same specimen, indwelling devices and a history of chronic skin wounds were significantly 
associated with CCCI when comparing to MRSA controls and controls without MRSA or VRE. 
Both factors were also significantly associated with CCCI in the main adjusted analysis when 
comparing all cases to MRSA controls. Biofilms may be influencing the development of MRSA 
and VRE CCCI and could provide a setting for gene transfer to occur for the development of 
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VRSA.Our study is limited by our inability to evaluate other molecular elements purported to drive 
VRSA emergence, including the Inc18-like plasmid found in enterococci and pSK41-like plasmid 
of S. aureus which have been hypothesized to facilitate conjugation between the two 
pathogens.149,186 VRSA isolates have been noted to either maintain the enterococcal Inc18-like 
plasmid or to insert the vancomycin resistance genes into a host plasmid, mediated by the 
transposon Tn1546.149,186 Previous research  using the same source population during similar time 
periods as our study have found unexpectedly low prevalence of these markers, which may explain 
the decrease in VRSA emergence in the region since the last identified isolate from Michigan in 
2009.187,188 
Other limitations were present in our study as well. Our use of stepwise regression can 
result in inappropriate inclusion or exclusion of covariates from our regression model which can 
bias the estimate of regression coefficients.189,190 We attempted to mitigate this problem by using 
prior knowledge of risk factors from previous CCCI and MDRO research to determine variable 
inclusion in the stepwise regression process.44,65,148,151–157,165,191 Our use of multiple comparison 
groups comes with potential limitations as well. We cannot statistically compare findings between 
groups, but can do a qualitative assessment, such as identifying variables associated with CCCI in 
multiple groups. Restrictions among the controls may result in comparisons with control groups 
that do not completely reflect the source population (i.e., all patients without CCCI), which could 
result in selection bias. However, these exclusions are likely a small percentage of the source 
population which lessens their effect on our findings. 
The potential risk factors of MRSA and VRE CCCI identified in this study demonstrate a 
connection between both healthcare exposure and the presence of other risk factors for multidrug-
resistant organism acquisition with CCCI. Interventions such as timely and effective treatment of 
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wounds, appropriate treatment of previous infections, avoiding unnecessary antimicrobial therapy 
and improved management of health-related issues could reduce the time individuals are at risk 
for co-colonization or co-infection with MRSA and VRE. Using the best practices for infection 
prevention in hospitals including surveillance, contact precautions, limiting time of hospital 
admissions and avoiding inappropriate antibiotic therapy including for patients colonized with 
MRSA and VRE can facilitate control of MRSA and VRE CCCI acquisitions preventing further 
VRSA emergence. Coupling of infection control practices with VRSA surveillance among patients 





Figure 2-1: Participant Inclusion Workflow 
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Table 2-1: Distribution of characteristics by case and control group. 
Characteristics MRSA/VRE 
CCCI 
(N = 134) 
MRSA 
Only 
(N = 109) 
VRE Only 
(N = 88) 
No MRSA or 
VRE 
(N = 99) 
Age 61 (52, 74) 57 (48, 70) 61.5 (50, 
70.5) 
60 (51, 69) 
Female 55 (41.0) 44 (40.4) 47 (53.4) 43 (43.4) 
Black 107 (79.9) 94 (86.2) 67 (76.1) 87 (87.9) 
Admission from Other Healthcare 
Facility 
73 (54.5) 30 (27.5) 43 (48.9) 21 (21.2) 
Altered Consciousness at Admission 53 (39.6) 27 (24.8) 31 (35.2) 25 (25.3) 
>0 Prior Hospitalizations (Past Year) 119 (88.8) 69 (63.3) 70 (79.6) 55 (55.6) 
Surgeries (Past 30 Days) 28 (20.9) 18 (16.5) 24 (27.3) 13 (13.1) 
Antibiotics (Past 30 Days) 96 (71.6) 58 (53.2) 55 (62.5) 30 (30.3) 
Previous MRSA Infection (Past Year) 31 (23.1) 21 (19.3) 10 (11.4) 3 (3.0) 
Current Medical Devices 87 (64.9) 40 (36.7) 50 (56.8) 30 (30.3) 
Diagnosis of Diabetes 64 (47.8) 54 (49.5) 44 (50.0) 33 (33.3) 
Renal Insufficiency 37 (27.6) 30 (27.5) 30 (34.1) 14 (14.1) 
History of Chronic Skin Wounds 76 (56.7) 30 (27.5) 49 (55.7) 9 (9.1) 
Steroid Use (Past 3 Months) 32 (23.9) 25 (22.9) 22 (25.0) 14 (14.1) 








































Continuous data includes median (Q1, Q3). 
Categorical data includes total (proportion). 
All variables included in the table except for Enterococcus species were included in subsequent 
stepwise models for adjusted analyses unless otherwise noted. 
Abbreviations: CCCI = Co-colonization or Coinfection; MRSA = methicillin-resistant 
Staphylococcus aureus; VRE = vancomycin-resistant Enterococcus; NA = Not Applicable 
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Table 2-2: Unadjusted Analysis of Patient Characteristics and Co-Colonization or Coinfection 
Status 
Characteristic MRSA Only VRE Only No MRSA or VRE 
 Odds ratio 
(95% CI)a 
pa Odds ratio 
(95% CI)a 
pa Odds ratio 
(95% CI)a 
pa 
Age 1.02 (1.00, 
1.03) 
0.07 1.00 (0.99, 
1.02) 
0.62 1.00 (0.99, 
1.02) 
0.87 
Female 1.08 (0.62, 
1.89) 
0.78 0.56 (0.29, 
1.08) 
0.08 0.93 (0.54, 
1.60) 
0.78 
Black 0.72 (0.35, 
1.47) 
0.37 1.44 (0.62, 
3.38) 
0.40 0.44 (0.18, 
1.06) 
0.07 




<0.0001 1.00 (0.51, 
1.96) 
1.00 4.56 (2.21, 
9.37) 
<0.0001 




0.009 1.00 (0.50, 
2.00) 
1.00 1.75 (0.95, 
3.23) 
0.07 




0.0001 2.43 (1.01, 
5.86) 
0.05 4.88 (2.28, 
10.43) 
<0.0001 
Surgeries (Past 30 Days) 1.31 (0.64, 
2.69) 
0.47 0.77 (0.37, 
1.57) 
0.47 1.60 (0.73, 
3.53) 
0.24 
Antibiotics (Past 30 Days) 2.83 (1.47, 
5.47) 
0.002 1.29 (0.69, 
2.44) 
0.42 7.43 (3.38, 
16.35) 
<0.0001 




0.33 2.83 (1.12, 
7.19) 
0.03 7.33 (2.20, 
24.50) 
0.001 
Current Medical Devices 5.00 (2.34, 
10.68) 
<0.0001 1.69 (0.85, 
3.36) 
0.13 3.67 (1.94, 
6.94) 
<0.0001 
Diagnosis of Diabetes 0.83 (0.45, 
1.52) 
0.54 1.00 (0.53, 
1.89) 
1.00 1.85 (1.07, 
3.19) 
0.03 
Renal Insufficiency 1.00 (0.49, 
2.05) 
1.00 0.90 (0.47, 
1.72) 
0.74 2.17 (1.09, 
4.29) 
0.03 




<0.0001 1.27 (0.64, 
2.49) 
0.49 17.33 (5.41, 
55.50) 
<0.0001 
Steroid Use (Past 3 Months) 1.13 (0.57, 
2.21) 
0.73 0.87 (0.41, 
1.82) 
0.71 2.09 (1.02, 
4.29) 
0.04 






































a. Odds ratios and p-values calculated using conditional logistic regression 
Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; VRE = vancomycin-




Figure 2-2: Forest Plot of Adjusted Analysis to Identify Risk Factors of Co-colonization or 
Coinfection. 
Odds ratios and p-values calculated using conditional logistic regression. All variables included in 
the models are present in the figure. 
Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; VRE = vancomycin-




Table 2-3: Adjusted analysis for the Association Between PVL Gene Presence and Co-
colonization or Coinfection 
Characteristic Odds Ratio (95% CI)a pa 
PVL Gene Present 0.087 (0.01, 0.74) 0.03 
Admission from Other Healthcare Facility 7.40 (1.55, 35.27) 0.01 
Surgeries (Past 30 Days) 0.18 (0.03, 1.02) 0.053 
Current Medical Devices 8.53 (1.41, 51.46) 0.02 
History of Chronic Skin Wounds 8.79 (1.31, 58.95) 0.03 
a. Odds ratios and p-values calculated using conditional logistic regression 
Restricted to cases and matched methicillin-resistant S. aureus controls (N=57) 
Race not included due to small cell sizes 




Figure 2-3: MRSA Isolate Sequence Type Flow Chart 




Table 2-4: Adjusted Analysis for the Association Between Clonal Complex and Co-colonization 
or Coinfection. 
Characteristic Odds Ratio (95% CI)a pa 
CC5 5.61 (1.49, 21.15) 0.01 
Altered Consciousness at Admission 4.39 (1.30, 14.79) 0.02 
History of Chronic Skin Wounds 8.80 (1.88, 41.14) 0.006 
a. Odds Ratios and p-values calculated using conditional logistic regression 
Restricted to cases and matched MRSA controls (N=58) 
Race, prior hospitalizations and surgeries in the past 30 days not included due to small cell sizes 
Abbreviations: CC = Clonal Complex; CI = Confidence Interval 
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Table 2-5: Unadjusted Analysis for Cases with MRSA and VRE Identified on the Same Day 
Characteristic MRSA Only (N=68)a VRE Only (N=54)a No MRSA or VRE 
(N=61)a 
 Odds ratio 
(95% CI) 
pa Odds ratio 
(95% CI) 
pa Odds ratio 
(95% CI) 
pa 
Age 1.01 (0.99, 
1.04) 
0.24 1.01 (0.99, 
1.03) 
0.41 1.01 (0.99, 
1.03) 
0.46 
Female 1.33 (0.63, 
2.82) 
0.45 0.71 (0.32, 
1.61) 
0.42 1.14 (0.56, 
2.34) 
0.72 
Black 0.60 (0.22, 
1.65) 
0.32 1.60 (0.52, 
4.89) 
0.41 0.25 (0.07, 
0.89) 
0.03 




0.02 0.63 (0.25, 
1.64) 
0.35 3.83 (1.56, 
9.41) 
0.003 




0.002 0.85 (0.38, 
1.89) 
0.68 2.00 (0.94, 
4.27) 
0.07 




0.005 1.80 (0.60, 
5.37) 
0.29 5.40 (2.08, 
14.02) 
0.0005 
Surgeries (Past 30 Days) 0.82 (0.34, 
1.97) 
0.66 0.78 (0.29, 
2.09) 
0.62 1.80 (0.60, 
5.37) 
0.29 
Antibiotics (Past 30 Days) 3.17 (1.27, 
7.93) 
0.01 1.44 (0.62, 
3.38) 
0.40 10.33 (3.16, 
33.80) 
0.0001 




0.68 2.00 (0.69, 
6.64) 
0.26 7.00 (1.59, 
30.80) 
0.01 
Current Medical Devices 3.29 (1.41, 
7.66) 
0.006 1.38 (0.55, 
3.42) 
0.49 4.00 (1.75, 
9.16) 
0.001 
Diagnosis of Diabetes 0.50 (0.23, 
1.11) 
0.09 1.27 (0.58, 
2.80) 
0.55 2.18 (1.07, 
4.54) 
0.03 
Renal Insufficiency 0.70 (2.67, 
1.84) 
0.47 0.75 (0.32, 
1.78) 
0.51 2.67 (1.04, 
6.82) 
0.04 




0.001 1.11 (0.45, 
2.73) 
0.82 17.50 (4.21, 
72.76) 
<0.001 
Steroid Use (Past 3 Months) 1.08 (0.49, 
2.37) 
0.84 0.91 (0.39, 
2.14) 
0.83 3.20 (1.17, 
8.74) 
0.02 






































a. Odds ratios and p-values calculated using conditional logistic regression 
Abbreviations: MRSA = Methicillin-Resistant S. aureus; VRE = Vancomycin-Resistant 
Enterococcus; CI = Confidence Interval 
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Table 2-6: Unadjusted Analysis for Cases with MRSA and VRE Identified in the Same Specimen 
Characteristic MRSA Only (N=50) VRE Only (N=42) No MRSA or VRE 
(N=45) 
 Odds ratio 
(95% CI)a 
pa Odds ratio 
(95% CI)a 
pa Odds ratio 
(95% CI)a 
pa 
Age 1.02 (0.99, 
1.06) 
0.14 1.02 (0.99, 
1.05) 
0.32 1.01 (0.98, 
1.04) 
0.45 
Female 1.00 (0.40, 
2.52) 
1.00 1.00 (0.38, 
2.67) 
1.00 1.09 (0.48, 
2.47) 
0.84 
Black 0.50 (0.15, 
1.67) 
0.26 1.25 (0.34, 
4.66) 
0.74 0.63 (0.20, 
1.91) 
0.41 




0.06 0.60 (0.22, 
1.65) 
0.32 2.80 (1.01, 
7.77) 
0.048 




0.07 0.63 (0.20, 
1.91) 
0.41 1.57 (0.61, 
4.05) 
0.35 




0.007 NAb NA 12.50 (2.96, 
52.77) 
0.0006 
Surgeries (Past 30 Days) 1.60 (0.52, 
4.89) 
0.41 0.70 (0.27, 
1.84) 
0.47 2.00 (0.60, 
6.64) 
0.26 
Antibiotics (Past 30 Days) 3.50 (1.15, 
10.63) 
0.28 1.14 (0.41, 
3.15) 
0.80 12.50 (2.96, 
52.77) 
0.0006 




0.17 2.50 (0.49, 
12.89) 
0.27 8.00 (1.00, 
63.96) 
0.0499 
Current Medical Devices 2.67 (1.04, 
6.82) 
0.04 1.00 (0.35, 
2.85) 
1.00 2.43 (1.01, 
5.86) 
0.048 
Diagnosis of Diabetes 0.42 (0.15, 
1.18) 
0.10 1.67 (0.61, 
4.59) 
0.32 4.00 (1.50, 
10.66) 
0.006 
Renal Insufficiency 0.70 (0.27, 
1.84) 
0.47 0.67 (0.24, 
1.87) 
0.44 2.60 (0.93, 
7.29) 
0.07 




0.007 1.50 (0.53, 
4.21) 
0.44 25.00 (3.39, 
184.50) 
0.002 
Steroid Use (Past 3 Months) 1.00 (0.40, 
2.52) 
1.00 1.00 (0.35, 
2.85) 
1.00 4.33 (1.24, 
15.21) 
0.02 







































a. Odds ratios and p-values calculated using conditional logistic regression 
b. Analysis not performed due to small cell sizes 
Abbreviations: MRSA = Methicillin-Resistant S. aureus; VRE = Vancomycin-Resistant 
Enterococcus; CI = Confidence Interval; NA = Not Applicable 
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Table 2-7: Prevalence of VRE Virulence Genes Among Cases and VRE Controls 
Gene MRSA/VRE CCCI (%) VRE Only (%) 
asa1 (N=22) 20 (90.9) 15 (68.2) 
gelE (N=22) 20 (90.9) 16 (72.7) 
hyl (N=22) 0 (0) 0 (0) 
esp (N=19)  7 (36.8) 7 (36.8) 
cylA (N=19) 1 (5.3) 2 (10.5) 
Abbreviations: MRSA = Methicillin-Resistant S. aureus; VRE = vancomycin-resistant 
Enterococcus; CCCI = Co-colonization or Coinfection
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Chapter 3:  The Role of Patient Functional Status in Environmental Contamination in the 
Hospital 
3.1: Author Summary 
Identifying patients at risk of contaminating their environment with multidrug-resistant 
organisms (MDRO) can guide infection prevention and control programs. We input patient 
characteristics into latent class analysis to classify patients based on functional status. We observed 
low functional status (LFS) patients contaminated their environment more frequently than high 
functional status patients. LFS patients may benefit from increased MDRO screening and more 
resources dedicated to patient hygiene and environmental cleaning and disinfection. 
3.2: Abstract 
Carriers of multidrug-resistant organisms (MDRO) can shed these organisms into the 
environment which can lead to pathogen transmission, especially in hospitals. Research assessing 
who contaminates their environment has focused on the measurement of bacterial load or presence 
at body sites but has been limited with regards to other characteristics of MDRO carriers which 
can affect bacterial load or a patients ability to interact with their environment, such as patient 
functioning, use of indwelling devices and antibiotic exposure. Detecting patients at increased risk 
of contaminating their environment may benefit decision-making for infection prevention and 
environmental decontamination policies. 
 We used data collected during a prospective cleaning intervention study at Shamir Medical 
Center in Israel from patients admitted between October 2016 and January 2018. Patients were 
screened at admission and during admission to identify patients positive for MDRO colonization. 
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Environmental samples were collected at one time point from five high-touch surfaces in the 
patient room for any organism detected during screening. Patient characteristics were used for 
latent class analysis (LCA) to categorize patients and determine associations between patient type 
and both any environmental contamination and contamination of all sites. 
 During the study, environmental samples were collected at 262 sampling points from the 
rooms of 211 MDRO carriers. Contamination of at least one site was detected in 163 (62.2%) of 
the sampling points and of all five sites in 33 (12.6%) sampling points. Requiring assistance with 
activities of daily living, altered consciousness at admission, and mechanical ventilation during 
admission were used for LCA to classify patients based on functional status. Low functional status 
(LFS) patients had higher odds of contaminating at least one site for all organisms (69.8% vs. 
52.2%; OR=2.2, 95% CI=[1.3, 3.7]; p=0.003), a composite of gram-positive bacteria (39% vs. 
18%; OR=2.4; 95% CI=(1.1, 5.4); p=0.03), MRSA (OR=2.3; 95% CI=[1.0, 5.2]; p=0.046) and a 
composite of gram-negative bacteria (74.7% vs. 59.4%; OR=2.0; 95% CI=[1.0, 3.9]; p=0.04). LFS 
patients also contaminated all sites more frequently for all organisms (OR=2.5; 95% CI=[1.1, 5.8]; 
p=0.03) and gram-positive bacteria (OR=8.7; 95% CI=[1.0, 73.6]; p=0.048). 
 LFS patients colonized with MDRO contaminated their environment more frequently than 
high functional status patients. These patients may be a target for infection prevention strategies 
including MDRO screening, isolation precautions, patient hygiene and more frequent 
environmental cleaning of high-touch surfaces. 
3.3: Introduction 
Antibiotic-resistant organisms are responsible for over 2,800,000 infections and over 35,000 
deaths each year in the United States.4 Treatment options are limited for multi-drug resistant 
organisms (MDRO), necessitating strategies for infection prevention and control, such as 
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environmental decontamination, to prevent MDRO transmission through the environment. In 
healthcare settings, carriers of MDRO can contaminate the environment and healthcare workers 
(HCW) with MDRO.38,40,192,193 This contamination has the potential to lead to MDRO transmission 
to other patients who subsequently occupy the same room or to patients in other areas through 
HCW and mobile equipment.42,80,194 Strategies to reduce MDRO environmental contamination, 
including staff education, enhanced cleaning, use of markers to ensure adequacy of cleaning and 
patient isolation precautions, have been effective in reducing the burden of these 
pathogens.97,195,196 Infection prevention control is costly and implementation of new programs 
redirects valuable time and resources from existing procedures. However, targeting these 
interventions toward programs which will be most beneficial for health outcomes of patients has 
been demonstrated to be cost-effective.196,197 
To apply infection prevention and control programs toward MDRO carriers, they must first 
be identified. While carriers with symptomatic infections would be identified through the standard 
clinical course among hospitalized patients, asymptomatic patients may go unnoticed without 
screening. Screening for MDRO carriers is expensive but targeted screening can produce a cost-
savings for hospitals.198 Determining patient factors which could result in environmental 
contamination can guide screening practices. Research on these characteristics has suggested some 
potential factors, including MDRO in bodily fluids, patient hand colonization, the number of body 
sites colonized and microbial concentration at the colonization site.82,109–111,199 These studies 
provide insight into the routes transmission of MDRO to the environment, such as through skin 
contact or from excreted bodily fluids. However, other factors may also contribute to 
environmental contamination. Physical ability to interact with the environment may influence the 
ability to contaminate one’s surroundings. The presence of indwelling devices may provide routes 
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for contaminated bodily fluids to contaminate the environment. Antibiotics may alter bacterial load 
at the colonization site.113 Studies analyzing a variety of patient traits which could be assessed at 
bedside or through the standard clinical care could allow for the identification of a type of patient 
more likely to contaminate the environment toward whom interventions could be directed. 
Latent class analysis (LCA) allows the grouping of individuals into classes of unobserved 
(latent) characteristics based on the relationships of observed characteristics. We can classify 
patients using observed characteristics into categories which are not observed or cannot be 
determined with a single measurement. These categorizations can be used to identify a patient type 
at risk for contaminating the environment more frequently. LCA provides several advantages for 
the analysis. With limited prior knowledge regarding associations between individual 
characteristics and environmental contamination, LCA can be used to build a model of patient 
types including multiple characteristics without requiring any additional knowledge. Traditional 
regression models require prior knowledge for the inclusion of variables. Following the assignment 
of class membership, associations between class membership and dependent outcomes can be 
determined. Class membership can be included in traditional regression models, allowing for the 
adjustment of confounders or investigation of interaction and effect modification if necessary. 
Previous research identified factors resulting in increased contamination which require 
additional testing (hand or body contamination, MDRO in bodily fluids and MDRO load at the 
colonization site). Characteristics which are observed without additional testing can provide 
information quickly and without additional cost to identify patients at increased risk of 
contaminating their environment. Infection prevention practices such as patient hygiene could then 
be directed toward these patients. We conducted a prospective cohort study using observable 
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patient characteristics to identify a hospitalized patient type among MDRO carriers who are more 
likely to contaminate their environment. 
3.4: Methods 
3.4.1: Study Setting and Data Collection 
Data for this study were collected as part of a larger prospective investigation regarding 
the efficacy of Clinell Universal Wipes (intervention) vs. bleach at a concentration of 1,000 ppm 
(standard hospital practice) for environmental cleaning in a hospital setting. Data were collected 
for patients admitted from October 20, 2016 through January 22, 2018 in four internal medicine 
units at the Shamir Medical Center in Israel. The study was divided into five periods 1) a one-
month pre-study period with bleach as the only cleaning agent used, 2) a six-month intervention 
period during which rooms in units A and D were cleaned with Clinell Universal Wipes and rooms 
in units B and C were cleaned with bleach, 3) a one-month washout period during which bleach 
was the only cleaning agent used, 4) a second six-month intervention period during which rooms 
in units B and C were cleaned with Clinell Universal Wipes and rooms in units A and D were 
cleaned with bleach ad 5) a one-month post-study periods during which bleach was the only 
cleaning agent used.  
Data regarding patient demographics, medical history and comorbidities were collected. 
Admission surveillance screening (within 48 hours of admission) for MDRO was performed for 
patients transferred from another hospital, patients transferred from another department within the 
hospital, functionally dependent patients, residents of long-term care facilities, patients 
hospitalized in an acute care hospital in the prior six months and prisoners. Additionally, as part 
of the infection prevention program at the hospital,  weekly MDRO screening was performed for 
ten patients at high-risk for infection as identified in previous research, including antibiotic 
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exposure, presence of indwelling devices, intensive care unit admission, and being bedridden.200,201 
Weekly screening of sputum was performed for all mechanically ventilated patients. Based on risk 
factors for organism acquisition, patients were screened for at least one, but not necessarily all, of 
the following multidrug-resistant organisms: 1) nasal screening for methicillin-resistant 
Staphylococcus aureus, (MRSA) 2) rectal screening for carbapenemase-producing carbapenem-
resistant Enterobacteriaceae (CP-CRE), non-carbapenemase-producing carbapenem-resistant 
Enterobacteriaceae (non-CP-CRE) and vancomycin-resistant Enterococcus (VRE) and 3) sputum 
screening of mechanically ventilated patients for multi-drug resistant Acinetobacter baumannii 
and Pseudomonas aeruginosa. MDRO-positive patients were placed in contact precautions and 
moved, when possible, to a single-patient room, or more commonly, to a multi-patient room with 
physical barriers placed between patients. 
Following a positive test, the environment was sampled at a single timepoint for any 
MDRO detected during patient screening; multiple samples were collected for patients positive for 
more than one MDRO meaning a patient could screen positive for different MDRO on different 
days and environmental sampling for those organisms could occur on different days as well. Five 
high-touch surfaces within the patient room were sampled (the right bedrail, the bedside table, 
underneath a binder with patient medical information hanging at the foot of the bed, the nurse’s 
call button and the lamp switch; Figure 3-1). These surfaces were subject to enhanced cleaning 
with bleach at a concentration of 1,000 ppm or Clinell® Universal Wipes and were cleaned daily 
when an MDRO carrier was identified. 
3.4.2: Statistical Analysis 
In LCA, individuals are classified into two or more classes based on responses to items 
included in the analysis.202 Classes can represent categories or characteristics of individuals not 
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otherwise measured. Two sets of class-level parameters are determined. Gamma is the probability 
that any individual will be a member of a class calculated as functions of logistic regression 
coefficients for inputted items. Rho is the response probability to each item given class 
membership. Parameters are estimated by maximum likelihood using expectation-maximization. 
Based on item responses for each covariate included in the analysis and the model parameters, 
posterior probabilities are generated, providing the probability an individual belonged to each 
class.  
To determine which variables would be included in the LCA analysis, we first investigated 
the relationship between these variables and environmental contamination. In our study, patients 
with any surface contamination for an organism and patients who contaminated all environmental 
sites with an organism were identified. Unadjusted analyses were performed using generalized 
estimating equations (GEE) with exchangeable correlation and clustering on individuals to identify 
relationships between individual characteristics and two separate outcomes when compared to 
individuals with no contaminated sites in the environment: either contaminating any environmental 
site with an organism or contaminating all sites with an organism. Clustering was used as more 
than one set of environmental samples could be collected from a patient room at different times if 
the patient screened positive for more than one organism. All GEE models used throughout the 
analysis included an exchangeable correlation structure and clustering on individuals. 
 Any significant (p<0.05) variables in the unadjusted analyses were included as items in 
LCA to categorize patients into groups based on their potential to contaminate their environment. 
Remaining variables were added individually and various class numbers were tested. Up to four 
variables and four classes were tested at a time. The maximum class size equaled the number of 
items in the LCA model. Models were compared using Akaike Information Criterion (AIC) and 
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Bayesian Information Criterion (BIC) and the model with the best fit was chosen. Individuals were 
assigned to the class with the highest posterior probability for that individual. 
Following the assignment of participants to latent classes, GEE models were used to 
identify associations between latent class membership and two outcomes 1) any environmental 
contamination with an organism vs. no contamination and 2) contamination all environmental sites 
with an organism vs. no contamination. These two analyses included all organisms. Because this 
data was collected during a cleaning intervention study, GEE models were used to compare any 
association between cleaning products used and latent class membership. Cleaning products were 
also included in separate models with latent class membership for both contamination outcomes 
to check for changes in effect measures and effect modification. No significant difference in 
environmental contamination was observed when between cleaning products in the prior research 
(unpublished data). 
GEE models were used to identify associations between latent class membership and 
contamination at each individual site for both contamination outcomes. The same model was used 
to identify associations between latent class membership and both contamination of any 
environmental site and contamination of all environmental sites with a composite of gram-negative 
organisms. Logistic regression was used to calculate associations between latent class membership 
and both contamination outcomes for each organism separately and for a composite of gram-
positive organisms.  
Inconsistencies were present in the time between patient screening and environmental 
sampling. Decolonization may occur for patients with longer times between screening and 
environmental sampling which could affect our ability to detect environmental contamination. 
GEE models were used for a sensitivity analysis to determine if time between either first positive 
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screen date or latest positive screen date and environmental sample collection (≤5 vs. >5 days) 
affected the detection of contamination at any site with an organism or contamination of all sites 
with an organism when all organisms were included. All  statistical analyses were performed using 
SAS version 9.4 (SAS Institute, Cary, NC) including the PROC LCA package (The Methodology 
Center, Penn State University College of Health and Human Development).202 
3.5: Results 
Data were collected for 9,362 patients during the study period; 211 patients screened positive 
for an MDRO and were in rooms where environmental samples were collected with no missing 
data for patient characteristics. The median age of the study population was 80 (interquartile range 
71-86) and 123 (58.3%) were male. Out of the total population, 98, 8, 7, 13, 100 and 36 patients 
were positive for MRSA, VRE, CP-CRE, non-CP-CRE, A. baumannii and P. aeruginosa 
respectively; environmental samples were collected at 262 sampling points. Environmental 
samples were collected at two sampling points for 39 (18.5%) patients and three sampling points 
for six (2.8%) patients. One individual who was included in the analysis and screened positive for 
MRSA did not have environmental contamination data from the lamp switch or call button. The 
frequency of positive admission screens and the time between positive screening dates and 
environmental sampling dates is in Table 3-1. Time between environmental sampling points and 
latest positive screen collection date was greater than ten days for five (1.9%) sampling points. At 
least one environmental site was contaminated in 163 (62.2%) sampling points and all 
environmental sites were contaminated in 33 (12.6%) sampling points. 
Three variables were significantly associated with environmental contamination at any site, 
requiring assistance with activities of daily living prior to admission, altered consciousness at 
admission and requiring mechanical ventilation during the admission (Table 3-2). Altered 
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consciousness at admission was also associated with contamination of all sites (Table 3-3). These 
variables were included in the latent class analysis. No other models with additional variables or 
classes were identified as a better fit. A two-class analysis was performed, resulting in 141 (52.8%) 
patients in class one (low functional status [LFS] class) and 126 (47.2%) patients in class two (high 
functional status [HFS] class) based on the highest posterior probability for each patient.  The 
probability of being positive for each variable included in the LCA was higher for the LFS class 
(Figure 3-2). The odds of any MDRO contamination was significantly higher for LFS patients 
(69.8% vs. 52.2%; OR=2.2, 95% CI=[1.3, 3.7]; p=0.003; Table 3-4). The odds of contaminating 
all sites vs. no sites was significantly higher for LFS patients (32.8% vs. 16.9%; OR=2.5; 95% 
CI=[1.1, 5.8]; p=0.03; Table 3-4). 
The bedrail was the most frequently contaminated site for all organisms (Table 3-5). The 
odds of contamination for LFS patients at each individual environmental site was significantly 
higher for all sites except for the call button (Table 3-4). 
Odds of contaminating at least one site was significantly higher for LFS patients when 
evaluating a composite of gram-positive organisms (39% vs. 18%; OR=2.4; 95% CI=[1.1, 5.4]; 
p=0.03; Table 3-4) and when evaluating MRSA (34% vs 16%; OR=2.3; 95% CI=[1.0, 5.3]; 
p=0.046;). The odds of contaminating all sites with gram positive organisms was significantly 
higher for LFS patients (13.5% vs. 1.8%; OR=8.7; 95% CI=[1.0, 73.6]; p=0.0048; Table 3-4). 
Odds of contamination of all sites with MRSA was higher, but not significantly, for LFS patients 
(20.7% vs. 3.9%; OR=6.5; 95% CI=[0.7, 58.4]; p=0.1). These analyses were not performed for 
VRE alone due to small sample sizes. 
When restricting to all gram-negative organisms, odds of contaminating any environmental 
site (74.7% vs. 59.4%; OR=2.0; 95% CI=[1.0, 3.9]; p=0.04) was significantly higher for LFS 
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patients (Table 3-4). A similar direction of effect, but not significant, was observed for A. 
baumannii and P. aeruginosa. The odds of contaminating all sites with all gram-negative 
organisms and A. baumannii were higher, but not significantly, for LFS patients (Table 3-4). 
Analyses of contamination at any site were not performed for CP-CRE and non-CP-CRE and 
analyses of contamination of all sites were not performed for CP-CRE, non-CP-CRE and P. 
aeruginosa due to small sample sizes. 
Sensitivity analyses were performed for all organisms (Table 3-6) to evaluate the effect of 
time from positive screen date to environmental sample collection date. Longer times between 
screening and sampling can result in a greater chance of patient decolonization, potentially causing 
missed contamination events. Stratified analyses were performed to determine whether time 
between screening and sampling confounded or modified the relationship between latent class 
membership and the contamination outcomes. The first analysis examined differences in 
contamination outcomes between the first positive screen collection date and the environmental 
sampling collection date (≤5 days vs. > 5 days). Both groups had a median of 5 days between first 
the screening date and the environmental sampling date (interquartile range of 3-6). The odds of 
contamination was greater for patients with more than five days between these dates for any 
contamination (OR=4.8; p=0.002 vs. OR=1.8; p=0.04) and contamination of all sites (OR=4.1; 
p=0.4 vs. OR=2.1; p=0.1). This is explained by the distribution of outcomes between LFS and 
HFS patients. The proportion of LFS patients was higher, but comparable, among those with 
greater than five days between the first positive screen collection date and environmental sample 
collection date for any contamination (72.0% vs. 68.7%) and lower, but comparable, for 
contamination of all sites (30.0% vs 34.0%). The proportions of HFS patients were lower for 
patients with five days between the first positive screening collection date and environmental 
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sample collection date for both any contamination (36.4% vs 58.8%) and all contamination (8.7% 
vs 21.4%). We did not observe a large decrease in the frequency of either contamination outcome 
among either of the patient groups for patients with >5 days between the first screening date and 
the environmental sampling date. This finding suggests environmental contamination events were 
not missed due to patient decolonization. 
The second sensitivity analysis examined differences in contamination outcomes between 
the latest positive screen collection date and the environmental sampling collection date (≤5 days 
vs. > 5 days). Both groups had a median of 4 days between latest screening date and the 
environmental sampling date (interquartile range of 2-5). The odds ratio was higher for patients 
with more than five days between the latest positive screen collection date and environmental 
sample date for any contamination (OR=6.7; p=0.003 vs. OR=1.9; p=0.04) but similar for 
contamination of all sites (OR=2.6; p=0.3 vs. OR=2.5; p=0.6; Table 3-6). The proportion of LFS 
patients was higher, but comparable, for patients with more than five days between the latest 
positive screen collection date and environmental sample date for any contamination (71.4% vs. 
69.4%) and lower, but comparable, for contamination of all sites (27.3% vs. 33.9%). The 
proportion of HFS patients was lower for patients with more than five days between the latest 
positive screening collection date and environmental sample date for any contamination (29.2% 
vs. 58.4%) and contamination of all sites (10.5% vs. 19.6%). We did not detect a large decrease in 
the frequency of environmental contamination for patients with >5 days between the latest 
screening date and the environmental sampling date. This finding indicates environmental 
contamination events were not missed due to patient decolonization. 
We determined if cleaning products affected the findings of the relationship between 
functional status and environmental contamination. In order to confound the association between 
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functional status and contamination, intervention arm would need to be associated with patient 
functional status. No direct or indirect causal pathway exists between cleaning products and patient 
functional status. Cleaning product may be associated with patient functional status by chance. 
After assessing any statistical relationship between cleaning products and patient functional status, 
no significant association was observed (OR=1.1; 95% CI=[0.6, 1.9]; p=0.7). A lack of association 
and no hypothesized relationship between cleaning products and patient functional status indicates 
cleaning products are not a confounder. When cleaning products were included in the models with 
patient functional status, the odds ratio and confidence interval of patient functional status were 
comparable to the main analysis for contamination of any site (OR=2.4; 95% CI=[1.4, 4.2]; 
p=0.046 vs. OR=2.2, 95% CI=[1.3, 3.7]; p=0.003) and for contamination of all sites (OR=3.6; 
95% CI=[1.4, 9.0]; p=0.008 vs. OR=2.5; 95% CI=[1.1, 5.8]; p=0.03). Cleaning product was 
associated with both any contamination (OR=3.9; 95% CI=[1.3, 3.8]; p=0.005) and contamination 
at all sites (OR=12.7; 95% CI=[3.3, 48.5]; p=0.0002). Because of this association, models were 
run to determine if cleaning product is an effect modifier. When including cleaning products and 
an interaction term between cleaning product and patient functional status in the model, the odds 
ratio of LFS patients were comparable to the main analysis for both contamination of any site 
(OR=2.4, 95%; CI=[1.4, 4.1]; p=0.002 vs. OR=2.2; 95% CI=[1.3, 3.7]; p=0.003) and 
contamination of all sites (OR=2.6; 95% CI=[0.7, 9.7]; p=0.2 vs. OR=2.5; 95% CI=[1.1, 5.8]; 
p=0.03). The interaction between cleaning product and patient functional status was not significant 
for any contamination (p=0.3) or contamination of all sites (p=0.5). Cleaning product is likely 
associated with contamination, but not functional status and is not a confounder or an effect 
modifier of the relationship between functional status and contamination. Cleaning product was 
not included in any other models. 
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3.6: Discussion 
We identified three factors associated with greater frequency of environmental 
contamination, altered consciousness at admission, requiring assistance with activities of daily 
living and requiring mechanical ventilation. Patients with a higher probability of these three traits 
were classified together as LFS patients and we found that this classification of patients 
contaminated at least one environmental site more frequently and all sites more frequently. The 
same result was observed when restricting to all gram-positive organisms. LFS patient 
contaminated at least one site with MRSA and all gram-negative organisms more frequently. LFS 
patients also contaminated all but one environmental site more frequently. These findings suggest 
a LFS patient type who has reduced mobility and physical capabilities and requires more 
interaction with HCW, which may facilitate environmental contamination, is more likely to 
contaminate the surrounding environment. Furthermore, they indicate the way which a patient 
interacts with their environment may play a role in environmental contamination. In our study, 
individuals’ functional status was assigned using probabilities determined during LCA, based on 
data collected easily collected from medical records or during clinical care. Research using a direct 
assessment of functional status for patients may provide greater insight unto its association with 
environmental contamination, but the findings presented here provide evidence that an association 
is present. 
Our findings may be due to multiple factors. Patients with limited mobility and altered 
consciousness may be unable attend to their personal hygiene, including hand hygiene. 
Colonization of patients’ hands in post-acute care facilities was observed to be a risk factor for 
environmental contamination in a previous study of 650 patients and rooms at six post-acute care 
facilities (p<0.001 for MRSA and VRE and  p=0.01 for resistant gram-negative bacilli).110 
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Associations between disabilities with activities of daily living and hand contamination were also 
identified in the study. We detected associations between environmental contamination for both 
MRSA and gram-negative bacteria in our research but could not analyze VRE alone due to the 
small number of VRE-positive patients. During an investigation of mechanically ventilated 
patients, Bonten et al. identified an association between the number of body sites colonized with 
VRE and environmental contamination.82 We did not explore relationships between body site and 
environmental contamination but patient hygiene may affect body site contamination, which could 
explain their findings. In another study, Cheng et al. observed a significant reduction of 
environmental contamination with MDRO in communal spaces following a resident hand washing 
intervention during a multi-site study of residential care homes.203 While most research regarding 
hand hygiene focuses on HCW, investigating the impact of patient hand hygiene, especially for 
those who cannot independently perform this task, may aid in infection control and prevention. 
The findings in our study may also result from low functioning patients who require more 
assistance from HCW. MDRO can be transmitted from patients to HCW, which could result in the 
contamination of the patient environment.39 This mode of contamination is supported in our study 
by the frequency of contamination in all patient rooms under the medical binder at the foot of the 
bed (between 14.3%-55.0% for all organisms except non-CP CRE). The binder, presumably, is 
primarily handled by HCW and contamination underneath it would likely be caused by HCW and 
not patients. Additional resources and precautions may be required for these patients to prevent 
contamination of fomites in the room through HCW. 
Mechanical ventilation was one of the factors used to determine functional status in our 
study and may contribute to environmental contamination. Lerner et al. found two patient factors 
associated with CRE contamination of the environment for patients from two internal medicine 
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wards in a tertiary care hospital: rectal CRE concentration and respiratory illness.111 The 
investigators posited that the association between respiratory illness and contamination was 
possibly due to immobility, physical limitation or antibiotic use. This may be indicative of a group 
of patients more likely to have respiratory illness with restricted mobility and physical limitations. 
These patients may require more HCW attention than others, providing a mechanism for 
environmental contamination.  
The link to between environmental contamination and contaminated bodily fluids from 
patients has been observed in other studies. Boyce et al. observed patients that with diarrhea and 
higher concentrations of MRSA in their stool contaminated their environment more frequently, in 
a study of eight patients with high MRSA levels in their stool and six patients negative for MRSA 
in the stool but positive at other body sites.109 Researchers in another study observed among 37 
consecutive patients admitted to a teaching hospital, patients with MRSA in wounds or urine 
contaminated their environment more than patients with MRSA at other body sites.199 Urine and 
wound secretions may provide routes for MDRO to contaminate the environment other than direct 
contact. These studies demonstrate release of contaminated bodily fluids may be a potential cause 
for increased environmental contamination, indicating secretions from other sites, such as 
respiratory secretions during mechanical ventilation, could contribute to contamination.  
Our results potentially contradict a previous study. Pilmis et al. conducted a prospective, 
hospital-wide study during which environmental samples were collected from five high-touch 
surfaces, twice in one day before and after cleaning, in 107 randomly selected patient rooms to 
detect contamination with any bacteria by total colony counts on brain-heart infusion agar.204 In 
multivariate analysis, three patient variables were associated with environmental contamination, 
including being a known MDRO carrier (OR=0.25; 95% CI=[0.09, 0.72]; p=0.01), being in a 
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single room (OR=0.3; 95% CI=[0.15, 0.6]; p=0.0005) and having a urinary catheter (OR=0.19; 
95% CI=[0.04-0.89]; p=0.03). A lower frequency of dependent patients was in contaminated 
rooms (25.9% vs 32%) and no significant association was observed between dependent status and 
contamination by univariate analysis (p=0.52). No effect measure was provided. Two comatose 
patients were included in the study, both contaminated the environment, but no significant 
association was observed during univariate analysis (p=0.49) and no effect measure was provided. 
This study had several limitations. Only 18% of patients in their analysis were known carriers of 
an MDRO through a medical record review. Time between identification of MDRO carriers and 
environmental sampling was not provided. Contamination with specific organisms was not 
investigated so potential relationships between carriers of specific organisms and contamination 
with those organisms could not be determined. These differences from our study may explain our 
contradictory findings. 
Our study did have some limitations. The long time from positive screen to environmental 
sampling for a small number of our patients may result in decolonization occurring prior to 
environmental sampling. However, our sensitivity analysis did not demonstrate a consistent 
reduction in the frequency of detecting contamination events for patients whose time between 
screening and sampling dates were long. Another potential limitation was the use of a maximum-
probability assignment method to classify patients during LCA, which can lead to an attenuation 
of results.205 However, we were still able to identify significant associations, even if attenuation 
was present. The lack of molecular analysis to confirm the organism identified from the patient 
was related to the organism in the environment is another limitation. This concern is somewhat 
mitigated by enhanced cleaning of the high-touch surfaces sampled in the study prior to movement 
of the colonized patients to the room, which may have reduced the likelihood that the organisms 
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detected in the environment were from other sources. We also sampled only one time point for 
each organism in each room, allowing for the potential to miss transient contamination episodes, 
potentially limiting our findings. However, our large sample size and sampling of five high-touch 
surfaces in the room provided us the opportunity to capture a large enough number of 
contamination events to support the analysis. A lack of repeat sampling would likely not impact 
our findings. Our screening criteria may limit our generalizability as patients screened were not 
from a hospital-wide population. Lastly, our study population median age was 80, possibly limiting 
the generalizability of our findings. 
LFS patients may contaminate their surrounding environment in hospitals with greater 
frequency than HFS patients. These patients may be candidates for MDRO screening during 
admission when they might not be otherwise. For LFS patients who are known MDRO carriers, 
they may be targets for other infection prevention practices, such as improved patient hygiene, 
staff education on cleaning and hygiene practices, isolation precautions and increased 
environmental cleaning and disinfection. Investigations into the mechanisms of contamination by 




Figure 3-1: Locations of Sampling Sites in the Patient Room. 
1) Right bedrail 
2) Bedside table 
3) Underneath a binder with patient medical information hanging at the foot of the bed 
4) Nurse’s call button 
5) Lamp switch 
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Table 3-1: Frequency of Positive Admission Screens and Time Between Positive Screen 
Collection Dates and Environmental Sampling Dates 
Organism Positive Admission 
Screena 
Time from Admission 
to First PSb 
Time from First 
PS to ESb 
Time from Latest 
PS to ES 
MRSA 59 (60.0) 1 (0, 61) 5 (1, 64) 4 (0, 18) 
VRE 6 (75.0) 0.5 (0, 14) 5 (5, 21) 5 (5, 7) 
CP-CRE 4 (57.1) 1 (0, 21) 2 (0, 13) 2 (0, 13) 
Non-CP-CRE 3 (23.1) 10 (0, 41) 6 (4, 7) 6 (0, 7) 
A. baumannii  19 (23.0) 10 (0, 56) 3 (0, 81) 3 (0, 28) 
P. aeruginosa 8 (22.2) 12 (0, 126) 5 (1, 35) 3.5 (0, 25) 
a. Screened within 48 hours of admission; frequency (percent) 
b. Time in days; median (interquartile range) 
Abbreviations: MRSA=Methicillin-Resistant S. aureus; VRE=Vancomycin-Resistant 
Enterococcus; CP-CRE=Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae; 
Non-CP-CRE=Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae; 
PS=Positive Screen Collection Date; ES=Environmental Sample Collection Date 
  
 65 
Table 3-2: Unadjusted Analysis of the Association Between Patient Characteristics with Any 
Environmental Contamination. 




OR (95% CI)b pb 
Age 79 (71, 86) 78 (70, 84) 1.0 (1.0, 1.0) 1.0 
Male 94 (57.7) 60 (60.6) 0.9 (0.5, 1.5) 0.7 




















0.7 (0.4, 1.3) 
1.0 (0.2, 4.2) 
1.0 (0.2, 6.1) 







LTCF Stay in Prior 3 Months 91 (55.8) 50 (50.5) 1.2 (0.7, 2.1) 0.4 
Hospitalization in Prior 3 
Months 
81 (49.7) 42 (42.4) 1.3 (0.8, 2.2) 0.3 
≥3 Outpatient Visits in Prior 3 
Months 
11 (6.8) 6 (6.1) 1.1 (0.4, 3.2) 0.9 
Hemodialysis 7 (4.3) 3 (3.0) 1.4 (0.4, 5.2) 0.6 
Requires Assistance in any ADL 
Prior to Admission 
132 (80.1) 69 (69.7) 1.9 (1.0, 3.4) 0.03 
Altered Consciousness at 
Admission 
106 (65.0) 47 (47.5) 2.1 (1.3, 3.6) 0.004 
Steroid 14 (8.6) 9 (9.1) 0.9 (0.4, 2.4) 0.9 
Immunosuppression 16 (9.8) 8 (8.1) 1.2 (0.5, 3.3) 0.7 
Diabetes 68 (41.7) 46 (46.5) 0.8 (0.5, 1.4) 0.5 
Permanent Device 53 (32.5) 27 (27.3) 1.3 (0.7, 2.3) 0.4 
Invasive Procedure in Past 6 
Months 
41 (25.2) 21 (21.2) 1.3 (0.7, 2.3) 0.5 
MDRO in Past 2 Years 46 (28.2) 34 (34.3) 0.8 (0.4, 1.3) 0.3 
Antibiotics in Past 3 Months 67 (41.1) 35 (35.4) 1.3 (0.8, 2.2) 0.4 
Mechanically Ventilated 60 (36.8) 24 (24.2) 1.8 (1.0, 3.3) 0.03 
a. Frequency (percent) for categorical variables and median (quartile 1, quartile 3) for continuous 
variables 
b. Odds ratios and P-values calculated with generalized estimating equations clustering on 
individuals. 
Abbreviations; PC=Positive Contamination; NC=Negative Contamination; LTCF=Long Term 
Care Facility; ADL=Activities of Daily Living; MDRO=Multidrug-resistant Organism 
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Table 3-3: Unadjusted Analysis of the Association Between Patient Characteristics with 
Contamination at All Sites. 







Age 78 (70, 86) 78 (70, 84) 1.0 (1.0, 1.1) 0.2 
Male 20 (60.6) 60 (60.6) 1.0 (0.5, 2.3) 1.0 




















0.7 (0.3, 1.7) 
0.6 (0.1, 7.4) 
0.6 (0.1, 7.4) 







LTCF Stay in Prior 3 Months 18 (54.6) 50 (50.5) 1.2 (0.5, 2.6) 0.7 
Hospitalization in Prior 3 
Months 
12 (36.4) 42 (42.4) 0.8 (0.3, 1.8) 0.5 
≥3 Outpatient Visits in Prior 3 
Months 
1 (3.0) 6 (6.1) 0.5 (0.1, 4.1) 0.5 
Hemodialysis 0 (0) 3 (3.0) -c - 
Requires Assistance in any ADL 
Prior to Admission 
28 (84.9) 69 (69.7) 2.6 (0.9, 6.9) 0.06 
Altered Consciousness at 
Admission 
22 (66.7) 47 (47.5) 2.3 (1.0, 5.3) 0.046 
Steroid 4 (12.1) 9 (9.1) 1.3 (0.4, 5.0) 0.6 
Immunosuppression 5 (15.2) 8 (8.1) 2.0 (0.6, 7.1) 0.3 
Diabetes 15 (45.5) 46 (46.5) 1.0 (0.4, 2.2) 1.0 
Permanent Device 10 (30.3) 27 (27.3) 1.2 (0.5, 2.9) 0.7 
Invasive Procedure in Past 6 
Months 
6 (18.2) 21 (21.2) 0.8 (0.3, 2.3) 0.7 
MDRO in Past 2 Years 11 (33.3) 34 (34.3) 1.0 (0.4, 2.2) 0.9 
Antibiotics in Past 3 Months 11 (33.3) 35 (35.4) 0.9 (0.4, 2.1) 0.8 
Mechanically Ventilated 10 (30.3) 24 (24.2) 1.4 (0.6, 3.3) 0.5 
a. Frequency (percent) for categorical variables and median (quartile 1, quartile 3) for continuous 
variables 
b. Odds ratios and P-values calculated with generalized estimating equations clustering on 
individuals. 
c. Not performed due to small sample size 





Figure 3-2: Probability of Positive Item Response in Latent Class Analysis by Class Membership 
 
Abbreviations: ADL=Activities of Daily Living; Class 1= Low Functional Status Patients; 
Class 2=High Functional Status Patients 
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Table 3-4: Association of Functional Status with Environmental Contamination for All 
Environmental Sites and by Site or Organism. 
Site or Organism Any Contamination Contamination of All Sites 
 Frequency (%) OR (95% CI)a pa Frequency 
(%) 







2.2 (1.3, 3.7) 0.003  
22 (32.8) 
11 (16.9) 





































































2.4 (1.1, 5.4) 0.03  
7 (13.5) 
1 (1.8) 







2.3 (1.0, 5.2) 0.046  
6 (20.7) 
1 (3.9) 
























2.0 (1.0, 3.9) 0.04  
15 (40.5) 
10 (26.3) 









































2.9 (0.9, 9.4) 0.08  
15 (75.0) 
9 (50.0) 














a. Odds ratios, 95% confidence intervals and p-values calculated for all sites, site specific, and 
gram-negative analyses using generalized estimating equations clustering for the individual and 
gram-positive and organism specific analyses using logistic regression. 
b. Site specific analyses for contamination of all sites not performed. 
c. Not calculated due to small sample size 
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Abbreviations: LFS=Low Functional Status Patients; HFS=High Functional Status Patients; 
GP=Gram-Positive Bacteria; MRSA=Methicillin-Resistant S. aureus; VRE=Vancomycin-
Resistant Enterococcus; GN=Gram-Negative Bacteria; CP-CRE=Carbapenemase-Producing 
Carbapenem-Resistant Enterobacteriaceae; Non-CP-CRE=Non-Carbapenemase-Producing 
Carbapenem-Resistant Enterobacteriaceae  
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Table 3-5: Frequency of Contamination by Site and Organism 
Contaminating Organism Bedrail Bedside Table Binder Call Button Lamp Switch 
MRSA 33 (33.7) 17 (17.4) 23 (23.5) 22 (22.7) 20 (20.6) 
CP-CRE 1 (14.3) 1 (14.3) 1 (14.3) 0 (0) 1 (14.3) 
Non-CP-CRE 1 (7.7) 0 (0) 0 (0) 0 (0) 0 (0) 
VRE 6 (75.0) 3 (37.5) 3 (37.5) 2 (25.0) 4 (50.0) 
A. baumannii 68 (68.0) 50 (50.0) 55 (55.0) 39 (39.0) 42 (42.0) 
P. aeruginosa 11 (30.6) 7 (19.4) 1 (22.2) 3 (8.3) 3 (8.3) 
Frequency includes total number (%) 
Abbreviations: MRSA=Methicillin-Resistant S. aureus; CP-CRE=Carbapenemase-Producing 
Carbapenem-Resistant Enterobacteriaceae; Non-CP-CRE=Non-Carbapenemase-Producing 
Carbapenem-Resistant Enterobacteriaceae; VRE=Vancomycin-Resistant Enterococcus 
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Table 3-6: Association of Functional Status with Environmental Contamination for All 
Organisms Accounting for Number of Days Between Patient MDRO Screen and Environmental 
Sample Collection 
Organism Any Environmental Contamination Contamination of All Sites 
 Frequency (%) OR (95% CI)a pa Frequency (%) OR (95% CI) a pa 
ES ≤6 days from first 











2.1 (0.8, 5.7) 0.1 
ES >6 days from first 











4.1 (0.7, 22.7) 0.4 
ES ≤6 days from latest 











2.5 (1.0, 6.2) 0.6 
ES >6 days from latest 











2.6 (0.4, 17.8) 0.3 
a. Odds ratios and P-values calculated with generalized estimating equations clustering on 
individuals. 
Abbreviations: MDRO=Multidrug Resistant Organism; LFS=Low Functional Status Patients; 
HFS=High Functional Status Patients; ES = Environmental Sample Collection Date; PS=Positive 
Screen Collection Date
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Chapter 4:  Antimicrobial-Resistant Bacteria and Viruses Detected Through Systematic 
Sampling in the Child Care Environment 
4.1: Author Summary 
We conducted a study at a single-classroom child care center to detect overall bioburden 
and frequency of contamination with viruses and antibiotic-resistant bacteria from nineteen 
environmental sites over seventeen sampling days during four months. Sites where children wash 
and play with water had higher median colony forming unit counts and were amongst the most 
frequently contaminated with pathogens. These sites would most benefit from enhanced cleaning 
and disinfection practices, such as cleaning basins and changing still water between play activities, 
to reduce the potential pathogen transmission through the environment. 
4.2: Abstract 
Approximately two-thirds of children under five years of age in the United States receive 
out-of-home child care. Child care attendees have an increased risk of infections compared to 
children not in child care settings, possibly due to their close contact in a shared environment and 
unique physiologic and developmental characteristics. As multidrug-resistant organisms 
(MDROs) increasingly move from healthcare to community settings, child care centers can 
provide a venue for further transmission of these pathogens. Our objective was to evaluate the 
bioburden of pathogens present on fomites in child care centers and to detect patterns of surface 
contamination over time. 
The study was conducted in a single classroom of an Ypsilanti, Michigan, child care center. 
Samples were collected from 19 sites (furniture, toys, room fixtures) for seventeen sampling days 
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from September 2019 to December 2019. Overall bioburden and frequency of contamination with 
viruses (adenovirus and norovirus), antibiotic-resistant bacteria (methicillin-resistant 
Staphylococcus aureus [MRSA], extended-spectrum beta-lactamase [ESBL]-producing 
Enterobacteriaceae, and vancomycin-resistant Enterococcus [VRE]), and fecal coliforms were 
detected. 
A total of 276 samples were collected. Sites where children washed or played with water 
had the highest median colony-forming unit counts, including the sink (3.0 log10 CFU/100 cm
2; 
IQR 2.3-3.3), water table basin (2.7 log10 CFU/100 cm
2; IQR 1.0-4.4) and water from the water 
table (3.4 log10 CFU/mL; IQR 3.0-4.0). The median CFU count for water-associated sites, 
excluding water samples, was significantly higher than all other sites (2.3 log10 CFU/100 cm
2; IQR 
1.9-3.2 vs. 1.79; IQR 1.5-2.2; p<0.0001). The most frequently contaminated sites for MRSA were 
the building block table (29.4%), wood blocks (29.4%), the water table basin (25%), and the 
imitation kitchen (17.7%). For extended-spectrum beta-lactamase-producing Enterobacteriaceae, 
the most frequently contaminated sites were the sink (35.3%), water from the water table (25%) 
and glue bottles (17.7%). The most frequently contaminated sites for adenovirus were the building 
block table (35.3%) and the water table tabletop (23.5%). 
The presence of MDRO and viruses on childcare center fomites raised concern for 
exposure to these pathogens among vulnerable populations. We found the highest bioburdens and 
most frequent contamination with pathogens on sites where children played or washed with water, 
identifying targets for environmental cleaning and disinfection practices to mitigate the potential 
spread of infections among children attending child care centers. 
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4.3: Introduction 
In the U.S., approximately 60% of children under five years-of-age receive child care in a 
regular arrangement with a non-parental provider.206 Infections are a major concern in child care 
centers (CCC’s). Child care attendees have an increased risk for respiratory and gastrointestinal 
infections and use more healthcare resources at a greater cost compared to children cared for at 
home.207,208  Pathogen transmission may occur between child care attendees and employees and 
their family members.123 Additionally, parents of attendees with child care-related illnesses face a 
direct socioeconomic burden due to the need to seek care for children as part of return-to-care 
requirements for ill children.209 
Multidrug-resistant organisms (MDRO) are a growing problem among young children of 
child care age. During a four-year, multicenter study including isolates recovered during routine 
clinical care for outpatients and hospitalized patients ≤21 years old, 201 extended-spectrum beta-
lactamase (ESBL)-producing Enterobacteriaceae isolates were recovered from patients with a 
median age of 4.3 years old and 91 AmpC-producing isolates were recovered from patients with a 
median age of 7.7 years old.210 Purcell and Fergie conducted a 14-year study at Texas children’s 
hospital, observing the proportion of S. aureus isolates resistant to methicillin increased from 
2.9%-10.6% in the first 10 years of the study and from 19.0%-62.4% final four years.116 The mean 
age of children with 749 MRSA infections from 2002-2003, the only time during the study with 
age data collected, was 7.9 years old. CCC’s provide a setting where MDRO transmission may 
occur. MRSA colonization has been detected in 0.14%-7.4% of child care attendees in several 
studies.121–124 In Laos, 92 (23%) screened children from 12 child care centers were positive for 
ESBL-producers.120 Investigations of MDRO transmission in child care centers could identify 
targets of intervention to prevent MDRO acquisition among young children. 
 75 
 Children may be more predisposed to infections due to immature immune systems and 
displaying behaviors that may facilitate pathogen transmission through the environment, such as 
mouthing of toys and exploring their environment through physical contact. The American 
Academy of Pediatrics (AAP) recommends comprehensive infection control and prevention 
practices, including environmental cleaning, sanitation and decontamination practices as one of 
the three major components of a healthy CCC setting.211 Children who attend CCC’s implementing 
infection control and prevention practices including environmental cleaning and decontamination 
practices have a reduced risk of infections while requiring less medical care and reducing parental 
absence from work.125 Inconsistent environmental decontamination recommendations between 
national organizations and local regulators result in reduced compliance with these guidelines.129 
Structured pathogen surveillance in CCC’s identifies patterns of environmental contamination 
which can guide cleaning and decontamination recommendations. 
 Longitudinal investigations of environmental contamination at CCC’s can better inform 
the role of contamination in pathogen transmission and the effectiveness of environmental 
decontamination strategies for reducing transmission. Our study aim was to demonstrate the 
feasibility of longitudinal environmental sampling for microorganisms in the CCC classroom to 
aid in cleaning and disinfection practices. Our objectives include determining the bioburden on 
fomites in a CCC and identifying the frequency of fomite contamination with bacterial and viral 
pathogens. 
4.4: Methods 
4.4.1: Study Setting 
The study was conducted at HighScope Demonstration Preschool, a CCC in Ypsilanti, MI. 
The school typically enrolls sixteen students, aged 3-5 years, for the academic year, and employs 
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two adult preschool instructors and a teacher’s aide. Students spend their time in a single room, 
except for a 30-minute recess (two times a day) at an adjacent outdoor playground, five days a 
week. We separated the classroom into five zones based on activity types (Figure 4-1). A single 
restroom and a second room, where food preparation and other staff activities occur, are adjacent 
to the classroom. 
Environmental samples were collected from September 2019 to December 2019, including 
17 sampling days. Samples were collected twice weekly, every Tuesday and Thursday for the first 
four weeks. Unexpected interruptions such as school closures for snow days and researcher 
illnesses disrupted the once weekly sampling plan for the following ten weeks. Samples were 
collected on nine days during those ten weeks, either on Tuesdays or Thursdays. The preschool 
staff maintained standard cleaning protocol throughout the study period. Staff regularly cleaned 
countertops and tables with 50-200 ppm bleach. Toys were cleaned in a dishwasher, approximately 
once every two months (some items excepted such as wooden blocks). Blankets and pillows were 
washed weekly, dress-up clothes were washed monthly or if soiled, and the carpet was cleaned 
twice a year. An outside cleaning crew cleaned the classroom daily using an Environmental 
Protection Agency-approved disinfectant with claims against emerging viral pathogens. The crew 
cleaned the bathroom, mopped the floors, vacuumed, and wiped down tables and hard surfaces. 
4.4.2: Environmental Sampling 
Sampling sites were selected to represent the assortment of furniture and toys with regular 
use by preschool students (Table 4-1) and found throughout the room (Figure 4-1). These fomites 
were sampled to capture the variety of sizes (large furniture to small toys), material types (wood, 
metals, plastic, water and laminate), and functionality (toys, furniture and other room features) of 
items found in the classroom. Toy samples were collected by randomly selecting individual toys 
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at each time point. Samples were collected at midday during the 30-minute recess following small 
group activities. Tables used for these activities were routinely cleaned by child care personnel 
prior to recess and before the sampling time point; no other items were cleaned during this time. 
Two samples were collected simultaneously using paired individual swabs for viral and 
bacterial samples. Viral samples were collected using PurFlock Ultra 6" Sterile Standard Flock 
Swab w/Plastic Handle (Puritan Medical Products, Guilford, ME) and swabs were moistened with 
Universal Transport Media (Copan Diagnostics, Murrieta, CA) and placed in the same media for 
transport following swabbing. Bacterial samples were collected with a regular flocked ESwab 
moistened with liquid Amies media (Copan Diagnostics, Murrieta, CA) and stored in the same 
media for transport. For larger items, an area of 700 cm2 was swabbed using a premade template; 
multiples of smaller items with less than 700 cm2 were swabbed to approximate the same surface 
area. Following sample collection, samples were transported to the lab and processed within an 
hour of collection. 
4.4.3: Standard Bacterial Plate Counts 
Following a ten-second vortex of the liquid amies samples with swabs, 100 µL of 
undiluted, 10-1, 10-2, and 10-3 concentrations of media were plated separately on tryptic soy agar 
(Neogen, Lansing, MI) and incubated at 37°C for 24 hours. Plates with colony counts between 20 
and 300 were used to calculate log10 colony-forming units (CFU)/100 cm
2 for surfaces and log10 
CFU/mL for water. If no plate from a single sample site had more than 20 colonies, then the 
undiluted sample was used to count CFU. 
4.4.4: Resistance and Fecal Coliform Testing 
Identification of methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum 
beta-lactamase (ESBL) producing Enterobacteriaceae, and vancomycin-resistant Enterococcus 
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(VRE) were performed using CHROMagar MRSA II (BD, Franklin Lakes, New Jersey), 
HardyCHROM ESBL (Hardy Diagnostics, Santa Maria, CA) and Spectra VRE (Thermo Fisher 
Scientific, Waltham, MA), respectively. Fecal coliform testing was performed using m-FC Agar 
with 1% Rosolic Acid (Hardy Diagnostics, Santa Maria, CA). At least one isolated colony from 
each selective media culture indicative of a positive result was cultured in tryptic soy broth 
(Neogen, Lansing MI) and stored in a 50% glycerol solution (Thermo Fisher Scientific, 
Waltham, MA) at -80°C.Viral Genomic Extraction 
UTM samples were vortexed for ten seconds with the swab; a volume of 1 mL of media 
was used for genomic extraction. Extraction was performed using High Pure Viral Nucleic Acid 
Large Volume Kit (Roche, Basel, Switzerland) with elution into 100 µL of elution buffer. Samples 
were further purified using RNA Clean & Concentrator-5 Kit (Zymo Research, Irvine, CA) with 
elution into 50 µL of elution buffer. Samples were stored at -80°C following elution with each kit. 
4.4.5: Viral PCR 
Singleplex PCR was used to identify the viral targets, adenovirus and norovirus (GI and 
GII). Adenovirus detection was performed using previously published primers, probes and 
protocols.212 PCR was performed using the AgPath-ID One Step RT-PCR Kit (Life Technologies, 
Carlsbad, CA) as previously described.212 FTD Respiratory pathogens 21 (Fast Track Diagnostics, 
Luxembourg) was included as a positive control for adenovirus during PCR.  
Norovirus GI and GII primers and probe sequences and thermocycler conditions have been 
previously described.213 A modification from previous methods to use two singleplex PCR assays 
for norovirus GI and GII was performed in this study. The same concentrations of primers, probes 
and buffers (AgPath-ID One Step RT-PCR Kit [Life Technologies, Carlsbad, CA]) were used as 
previously published.213 Two norovirus positive controls were included during PCR (norovirus GI 
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- ATCC VR-3234SD; norovirus GII - ATCC VR-3235SD). All PCR assays were performed using 
the Applied Biosystems 7500 (Thermo Fisher Scientific, Waltham, MA). 
4.4.6: Statistical Analysis 
Median CFU counts and frequency of contamination with antibiotic-resistant bacteria were 
calculated. The Wilcoxon rank-sum test was used to compare median CFU counts between sites. 
All statistical analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC). 
4.5: Results 
A total of 276 samples were collected from 19 sites in the classroom on 17 different days; 
13 of the 19 sites had samples collected on all 17 days (Table 4-2). Sampling of the side and bottom 
of Large Table 2 started on the second day of sample collection. Water sampling from the water 
table was began on the third day of sampling. On the four days water was not present, samples 
were collected from the water table basin. Sampling of the toy trains began on the third sampling 
day. Sampling of chairs began on the seventh sampling day. A camera mounted on a wall out of 
the reach of the children was sampled on three days. The median time between sampling days was 
5 days, with a range of 2-16 days.  
Twelve sites were positive for bacterial growth from all samples collected (Table 4-2). The 
range of the frequency of positive samples was 83%-100% for all sites. The log10 CFU/100 cm
2 
(or log10 CFU/mL for water) was determined for all samples with bacterial growth. The median 
CFU count for all sites excluding water samples was 1.8 log10 CFU/100 cm
2 (interquartile range 
[IQR] 1.5-2.3). The sites with the highest median CFU counts were sites where children washed 
or played with water including the sink (3.0 log10 CFU/100 cm
2; IQR 2.3-3.3), water table basin 
(2.7 log10 CFU/100 cm
2; IQR 1.0-4.4) and water from the water table (3.4 log10 CFU/mL; IQR 
3.0-4.0). Among the classroom furniture, samples collected from the building block table (2.4 log10 
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CFU/100 cm2; IQR 2.3-3.6) and the imitation kitchen (2.2 log10 CFU/100 cm
2; 1.8-2.3) had the 
highest median CFU counts. The small wood blocks were observed to have the highest median 
bioburden among the toys (2.4 log10 CFU/100 cm
2; IQR 2.0-2.9). CFU counts ranged from 0.63-
4.68 log10 CFU/100 cm
2 among all water-associated sites, excluding water samples, and 0.15-3.67 
log10 CFU/100 cm
2 for all other sites (Figure 4-2). 
The median bioburden of all water-associated sites, excluding water collected from the 
water table, was significantly higher than the bioburden at all other sites (2.3 log10 CFU/100 cm
2; 
IQR 1.9-3.2 vs. 1.8 log10 CFU/100 cm
2; IQR 1.5-2.2; p<0.0001; Figure 4-2). Among the tables, 
the median CFU count for the building block table, which has an irregular surface, was 
significantly higher than the two large tabletops (2.4 log10 CFU/100 cm
2; IQR 2.3-2.6 vs. 1.5 log10 
CFU/100 cm2; IQR 1.1-1.8; p<0.0001). The median CFU count for the imitation kitchen, which 
has a large smooth surface, was significantly higher than for the other two large tabletops (2.2 
log10 CFU/100 cm
2; IQR 1.8-2.3 vs. 1.5 log10 CFU/100 cm
2; IQR 1.1-1.8; p = 0.0002). Among the 
toys, the wood blocks had a higher median CFU count than all other toys (2.4 log10 CFU/100 cm
2; 
IQR 2.0-2.9 vs. 1.7 log10 CFU/100 cm
2; IQR 1.5-2.0; p<0.0001). 
 Twenty-two out of 276 total samples (8.0%) were positive for MRSA. Eleven sampling 
sites were positive on at least one occasion (Table 4-2). The sites most frequently contaminated 
with MRSA included the building block table (n=5; 29.4%), the small wood blocks (n=5; 29.4%), 
the water table basin (n=1; 25%) and the imitation kitchen (n=3; 17.7%).  
Seventeen samples out of 276 total samples (6.2%) were positive for ESBL-producing 
Enterobacteriaceae; seven sampling sites were positive on at least one occasion (Table 4-2). The 
sink (n=6; 35.3%), water from the water table (n=3; 25%) and the glue bottles (n=2; 17.7%) were 
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contaminated most frequently with ESBL-producers. No samples were positive for VRE or fecal 
coliforms from any site. 
 Twenty-one total samples (7.6%) were positive for adenovirus. Samples from nine sites 
were positive for adenovirus on at least one occasion (Table 4-2). The most frequent sites of 
adenovirus contamination were the building block table (n=6; 35.3%) and the water tabletop (n=4; 
23.5%). Norovirus was not detected in any sample. 
4.6: Discussion 
Our study demonstrates the feasibility of a longitudinal sampling investigation in a child 
care center to detect environmental contamination with bacterial and viral pathogens on various 
fomites. We identified adenovirus and antibiotic-resistant bacteria in the environment, indicating 
the potential for fomites to facilitate transmission of these pathogens. The bioburden was generally 
low and contamination with pathogens was absent or infrequent at most sites. However, sites 
where children washed and played with water and fomites with irregular surfaces or cleaned less 
frequently harbored higher bioburdens and were contaminated more frequently with pathogens. 
The median bioburden detected for sites in our study is in line with other previous research. 
Li et al. detected a median of 2.04 log10 CFU/100 cm
2 for  smooth surfaces from 40 CCC’s with a 
mean of eight samples collected per site.214 Our findings are similar to their results. During twice 
monthly sampling from six CCC’s over eight months, Cosby et al. detected mean counts of 1.64 
log10 CFU/50 cm
2, 1.58 log10 CFU/50 cm
2, and 1.53 log10 CFU/50 cm
2 for food serving, diaper 
changing and food preparation areas.143 We did not sample from surfaces used for these activities, 
but we did find similar bioburden on other large, smooth furniture. 
Our surveillance identified several locations with higher levels of contamination. Most 
notably, sites were children wash and play with water, the sink and water table (including the 
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tabletop, basin and water from the basin), were among the highest bioburden sites and most 
frequently contaminated with pathogens. Water can act as a reservoir for microbes and spreads 
these organisms to surrounding areas during hand hygiene and play activities. These water-
associated sites may benefit from more frequent cleaning. The AAP, in conjunction with American 
Public Health Association, and the National Resource Center for Health and Safety in Child Care 
and Early Education recommend water tables should  be filled before their use and the basin should 
be cleaned after each use.127 They also recommend children should wash their hands before and 
after using the water table to limit the spread of pathogens. Our findings support these 
recommendations. 
 Some fomite surfaces may be irregular and difficult to clean. The building block table in 
our study, which had the highest median bioburden of the furniture, is an example. The tabletop 
for the building block table contains many ridges, making this surface more difficult to clean than 
a flat tabletop, potentially explaining the increased contamination. Li et al. observed significant 
differences in aerobic plate counts and coliform counts when contamination on regular and 
irregular surfaces were compared in 40 CCC’s, demonstrating surface type can play a role in 
contamination.214 Irregular surfaces may require special attention and cleaning instruments other 
than cloth like scrubbing brushes. 
Materials which are difficult to clean may result in higher contamination due to less 
frequent cleaning. The small wood blocks were identified as having a higher median bioburden 
and were more frequently contaminated among the toys. The blocks are not typically cleaned like 
the other toys as the wood may be damaged during cleaning, potentially explaining their higher 
and more frequent contamination. Contamination of toys that cannot be cleaned regularly could 
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be managed by rotating toys out of circulation to allow organisms to die off before being used 
again. 
Frequency and timing of cleaning may also affect the detection of contamination among 
other furniture. The imitation kitchen has a similar surface to the large tables in the room. However, 
the large tables were cleaned by the staff following small group activities which immediately 
preceded environmental sampling while the imitation kitchen was not cleaned. The large tables 
had a low median bioburden and limited pathogen contamination, potentially demonstrating the 
impact of frequent environmental cleaning. Both the furniture and toy results demonstrate frequent 
cleaning can effectively reduce bioburden in the environment. 
Material type may also play a role in the recovery of organisms from fomites. Several 
studies have demonstrated bacterial transfer and survivability is reduced for wood compared to 
other materials, including plastics and metals.215–219 Wood is porous, providing space for bacteria 
to inhabit making recovery difficult and causing the surface to dry more quickly than non-porous 
materials which can reduce the survival of organisms.215 Furthermore, surfaces such as plastics, 
which appear smooth macroscopically, may have microscopic crevices which improve adherence 
of organisms to the surface and can protect organisms from desiccation. Recovery and 
survivability of bacteria on smooth surfaces without microscopic crevices, such as glass, is 
reduced, as these surfaces do not protect against desiccation.215 In our study, we observed a high 
median bioburden on the wood blocks. As viability and recovery from wood is expected to be 
reduced, the higher level of contamination suggests the contamination is likely more recent or 
occurring with a larger inoculum than on other materials as we would expect a lower bioburden if 
the timing or amount of contamination was similar between sites. For plastic and metal fomites, 
recovery of bacteria is expected to be similar when accounting for time from contamination and 
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bacterial load during contamination.215–219 If this is the case for the materials sampled in this study, 
differences among these materials may therefore be related to frequency and quality of cleaning. 
We detected adenovirus on a variety of surfaces. Adenovirus is a common cause of 
respiratory and gastrointestinal disease among children, and has caused illness outbreaks in 
CCC’s.220–222 Transfer of adenovirus from the environment to human skin has been demonstrated 
experimentally, indicating its potential for environmental transmission. Adenovirus environmental 
contamination has been implicated in illness outbreaks. Sammons et al. identified contaminated 
ophthalmologic equipment as the source of an adenovirus outbreak in a neonatal intensive care 
unit.223 Detection of adenovirus in our study could signify transmission of adenovirus through the 
environment is possible. Adenovirus has been detected in the environment of CCC’s previously. 
Lyman et al. identified environmental contamination from 13 of 22 CCC’s with acute 
gastroenteritis outbreaks in North Carolina, including contamination with adenovirus at 10%-
100% of sampled sites during three outbreaks.132 The frequency of contamination with adenovirus 
in this study was higher than ours, which could be due to the presence of illness outbreaks during 
their study. 
MDRO in child care requires more investigation. In our study, contamination with 
antibiotic-resistant bacteria was infrequent, including limited contamination with ESBL-producers 
and no contamination with VRE. Research regarding environmental contamination in CCC’s with 
these pathogens is sparse. Moritz et al. detected MRSA in 1.4% of cross-sectional samples from 
eleven CCC’s in Iowa.144 Our study detected a higher frequency of contamination, which may be 
due to differences in susceptibility testing (selective media vs. broth microdilution). In two 
California CCC’s, 6% of fomites were contaminated with any Enterococcus spp. and none were 
contaminated with E. coli. However, antibiotic resistance was not investigated.224  
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Our lack of fecal coliform contamination does not correspond with previous research. 
Researchers in Tennessee detected total coliforms in 24.7% of environmental samples at six 
CCC’s. However, they did not distinguish between total and fecal coliforms. Also, the sites 
sampled were food contact surfaces and diaper changing stations, which may explain the 
difference in findings. Researchers from three previous studies found low proportions of fecal 
coliform contamination of fomites (3.0%, 4.3% and 9.5%), differing from our findings of no 
contamination, but still infrequent.136,138,224 In a longitudinal study including ten rooms from six 
CCC’s, fecal contamination was detected on 26 fomites, ranging 2-52% for each item.135 The ages 
of the attendees were 24 months and younger. These attendees are younger than those in our study 
and would still require diapering, potentially accounting for the higher contamination rates. 
The small class size and single classroom may limit the amount and variety of 
environmental contamination found in our study and could reduce the generalizability of our 
findings. However, the repeated sampling and number of sampling sites would help mitigate these 
limitations. We also used selective media to identify MDRO in the environment. Susceptibility 
testing using selective media may result in reduced sensitivity and specificity when compared to 
traditional culture methods but are still highly effective at detecting antibiotic resistant 
organisms.225–227 If the prevalence of MDRO in the environment is low in CCC’s then our findings 
will overestimate the frequency of contamination, even with a high sensitivity and specificity for 
the selective media. 
For environmental pathogen transmission to occur, viable organisms must be present. We 
demonstrated the viability of the bacteria detected through culturing, but our viral detection was 
PCR-based only, limiting our study. Ganime et al. detected viable adenovirus from 50% of 
environmental samples that were PCR-positive.228 Viable organisms need to inoculate the host 
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directly, as may occur with mouthing of fomites among young children, or mediated through the 
host’s hands. The efficiency of organism transfer from the environment to hands and then from 
hands to inoculation sites is low for viruses and bacteria, including multi-drug resistant organisms 
(MDRO).229–232 However, low doses of inoculation can still result in infection.233,234 Studies 
regarding transfer of organisms to hands and inoculation sites were performed on adults and may 
not be generalizable to children. Children use their hands to explore the environment and their own 
bodies which may provide more opportunities for bacterial transfer and self-inoculation. 
Developmental, behavioral and environmental factors present unique challenges to 
controlling infections in child care centers. We have demonstrated the feasibility and importance 
of longitudinal surveillance of key child care center environmental sites for various organisms. 
Our research identified problem areas within the classroom, which can guide targeted infection 
control practices when time and resources are limited. With this uncertainty and the threat of 
environmental transmission of other pathogens, vigilance with best practices for environmental 
decontamination should be maintained. 
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Table 4-1: Items Sampled, Material Type, Sampling Instructions Corresponding Sampling 
Numbers 
Item Sampling Instructions Sample 
No. 
Large Table 1 (Laminate) Use template on the table edge and tabletop 1 
Sink (Stainless Steel) Swab the upper edge around the entirety of the basin 2 
Waste basket (Plastic Bag) Swab the entire upper edge covered by the trash bag 3 
Glue Bottles (Plastic) Holding the bottle top, swab the entire bottle 4 
Water Table Tabletop (Laminate) Use a template on the center of the tabletop 5 
Large Table 2 - Top (Laminate) Use template on tabletop 6 
Teflon Toy Pots (Teflon/Metal) Swab the entire pot 7 
Imitation Kitchen (Laminate) Use a template on the center of the countertop 8 
Doll (Plastic) Holding the clothed area, swab the unclothed area 9 
Building Block Table (Plastic) Use a template on the center of the tabletop 10 
Building Blocks (Plastic) Swab the entire block 11 
Crib (Wood) Swab the upper and lower wood board on one long edge 
of the crib 
12 
Large Table 2 – Edge and Bottom 
(Laminate/Wood) 
Swab the edge and bottom using curved template 13 
Small Wood Blocks (Wood) Swab the entire surface of the block 14 
Water from Water Table (Water) Collect at least 10 mL by submerging a sterile container 
in the water 
15 
Toy Train (Mixed – Wood, Plastic, 
Metal) 
Swab the entire small train piece 16 
Chair (Wood) Swab the outer edge of the seat and back (both sides of 
the back 
17 
Camera Stand (Plastic) Swab the base of the camera (done monthly) 18 
Water Table Basin (Plastic) Use template on basin (only to be performed if no water 






Figure 4-1: Room Layout and Location of Sampling Sites. 
Numbers correspond to sample numbers in table 1. Double headed arrows indicate room 
entrance/exit. 
Abbreviations: BT = Building Block Table; C = Crib; RR = Restroom; S = Shelves; Si = Sink; T 
= Table; WT = Water Table 
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Table 4-2: Colony-forming Unit Counts and the Frequency of Antibiotic-Resistant Bacteria and 




















1 17 15 (88) 1.6 (1.2, 2.1) 0 (0) 0 (0) 0 (0) 
2 17 17 (100) 3.0 (2.3, 3.3) 1 (5.9) 6 (35.3) 1 (5.9) 
3 17 17 (100) 1.8 (1.5, 2.0) 1 (5.9) 0 (0) 0 (0) 
4 17 17 (100) 2.0 (1.9, 2.2) 1 (5.9) 2 (17.7) 1 (5.9) 
5 17 17 (100) 2.0 (1.8, 2.3) 1 (5.9) 2 (11.8) 4 (23.5) 
6 17 16 (94) 1.4 (1.0, 1.7) 0(0) 0 (0) 0 (0) 
7 17 17 (100) 1.8 (1.6, 1.9) 1 (5.9) 0 (0) 2 (11.8) 
8 17 17 (100) 2.2 (1.8, 2.3) 3 (17.7)  1 (5.9) 0 (0) 
9 17 16 (94) 1.7 (1.5, 2.0) 1 (5.9) 0 (0) 2 (11.8) 
10 17 17 (100) 2.4 (2.3, 2.6) 5 (29.4) 2 (11.8) 6 (35.3) 
11 17 16 (94) 1.5 (1.2, 2.0) 0 (0) 0 (0) 0 (0) 
12 17 14 (88)c 1.2 (0.8, 1.7) 2 (11.8) 0 (0) 0 (0) 
13 16 15 (94) 1.6 (1.1, 2.3) 0 (0) 1 (6.3) 2 (12.5) 
14 17 16 (100)c 2.4 (2.0, 2.9) 5 (29.4) 0 (0) 1 (11.8) 
15 12 10 (83) 3.4 (3.0, 4.0)b 0 (0) 3 (25) 0 (0) 
16 15 13 (100)d 1.7 (1.7, 1.9) 0 (0) 0 (0) 2 (13.3) 
17 11 11 (100) 1.5 (1.3, 1.8) 0 (0) 0 (0) 0 (0) 
18 3 3 (100) 1.8 (1.6, 1.9) 0 (0) 0 (0) 0 (0) 
19 4 4 (100) 2.7 (1.0, 4.4) 1 (25) 0 (0) 0 (0) 
a. Sample no. corresponds to the sample no. in Table 4-1 
b. Log10 CFU/mL for water 
c. One sample not processed for standard bacterial plate count due to contamination 




Figure 4-2: Distribution of CFU counts for Water-Associated Sites and Other Sites 
The histogram (top) and box plot (bottom) show the distribution of colony-forming unit (CFU) 
counts transformed to log10 CFU/100 cm
2 for all samples collected where children wash and play 
with water (excluding water samples) compared to all samples collected from other sites. A normal 
curve and fitted curve are overlayed over the histogram. The median CFU count for water-
associated sites was significantly higher than for all other sites by the Wilcoxon rank-sum test. 
 91 
Chapter 5:  Conclusions 
 
The overall goal of this work was to identify targets for infection prevention and control 
measures to interrupt multidrug-resistant organism (MDRO) transmission and acquisition. This 
dissertation investigated two topics, ascertaining the risk of multiple organism colonization and 
infection, a potential preceding event to MDRO acquisition, and environmental contamination 
with MDRO, which contributes to pathogen transmission. In chapter 2, risk factors for methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) co-
colonization or coinfection (CCCI), a likely predecessor to vancomycin-resistant S. aureus 
(VRSA) acquisition, were determined for hospitalized patients in the region with highest number 
of VRSA cases detected in the U.S. In chapter 3, we used patient characteristics to identify a type 
of MDRO carrier among hospitalized patients that contaminates the surrounding environment. 
Finally, surveillance of a CCC classroom in chapter 4 revealed multiple locations in the 
environment harboring a higher bioburden and more frequently contaminated with potential 
pathogens. A summary of these findings is discussed here, focusing on the knowledge added, 
public health implications, strengths, weakness and future considerations. 
5.1: Aim 1 
5.1.1: Aim 1 Knowledge Added and Implications 
The emergence of VRSA demonstrates the potential for de novo MDRO emergence 
through horizontal gene transfer during multiple organism colonization or infection. However, the 
dearth of cases and the lack of person-to-person transmission provides an opportunity to  intervene 
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on VRSA emergence and contain its dissemination.148 Molecular and epidemiological evidence 
suggest MRSA acquires vancomycin resistance from VRE during CCCI resulting in VRSA 
acquisition, a serious concern considering vancomycin is a first-line treatment option for 
MRSA.65,148–150,235 Since the majority of all documented U.S. VRSA cases occurred in southeast 
Michigan, determining risk factors for MRSA and VRE CCCI in this population can be of 
enhanced importance to prevent the continued emergence of VRSA.  
We observed that healthcare exposure was a risk factor for MRSA and VRE CCCI. MDRO 
infections are a common problem in healthcare facilities, including MRSA and VRE, so this 
finding is not surprising.34 Warren et al. identified prior hospitalization and admission from another 
healthcare facility and a Han et al. identified prior hospitalizations as risk factors for CCCI. 151,154 
We build on this evidence using molecular characteristics of pathogens. Admission from another 
healthcare facility was identified as a risk factor when comparing CCCI patients with MRSA 
controls and controls without MRSA or VRE in our study. Having at least one hospitalization in 
the past year was a risk factor when comparing to MRSA controls, further implicating healthcare 
exposure as a CCCI risk factor. Our molecular analysis revealed patients harboring PVL-negative 
MRSA isolates and CC5 MRSA isolates were at greater risk of CCCI with VRE. PVL-positive 
MRSA isolates have been associated with community-associated MRSA strains and CC5 isolates 
are associated with healthcare-associated MRSA, providing additional evidence that healthcare 
exposure may be a risk factor for CCCI.169,173 Molecular analysis  is sparse in prior CCCI research 
and is a strength our study. The totality of our findings strengthens the observation that healthcare 
exposure is a risk factor for CCCI. 
Our findings can inform infection prevention and control practices. Transfer of patients 
between healthcare facilities presents an opportunity for introduction and transmission of MDRO 
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between settings. Communication of MDRO carrier status between facilities can aid in 
identification of MDRO carriers. The Centers for Disease Control and Prevention (CDC) 
recommends screening of patients transferred from healthcare facilities known to have a high 
prevalence of MDRO.236 Our findings add more support for this recommendation. The CDC also 
recommends cohorting patients with the same MDRO when single-patient rooms are not 
available.236 In this case, screening can be beneficial as to prevent cohorting of patients with 
MRSA together when one is an unknown VRE carrier, or vice versa, particularly for patients with 
CCCI risk factors. Screening can aid antibiotic stewardship, another infection control strategy 
recommended by the CDC.236 In the case of multiple organism colonization or infection, using 
vancomycin on a patient with MRSA who unknowingly harbors VRE, may result in killing 
susceptible bacteria while allowing resistant organisms, such as VRSA, to grow with reduced 
competition. Recent antibiotic exposure was also a risk factor for CCCI when comparing to 
controls without MRSA or VRE, providing further support for antibiotic stewardship.  
The CDC recommends enhanced barrier precautions when caring for residents in long-
term care facilities with indwelling devices to prevent the transmission of MDRO, which is 
supported by our findings.236 Our research and other CCCI research identified indwelling devices 
as a risk factor for CCCI and barrier precautions may reduce MDRO acquisition among 
hospitalized patients.153,154,156 Device-associated infections were responsible for 179,639 (57.6%) 
healthcare associated infections reported to the National Healthcare Safety Network from 2015-
2017, including antibiotic-resistant infections in 0.7-82.1% of cases depending on the organism.34 
The Society for Healthcare Epidemiology of America (SHEA) recommends judicious use of 
indwelling devices and implementing appropriate sterile techniques for the placement, 
management and removal of these devices, which our findings support.237 Judicious use of 
 94 
indwelling devices can improve patient outcomes. For example, Burnham et al. observed failure 
to remove a central venous catheter was a risk factor for all-cause 30-day mortality (HR=13.5; 
95% CI=[6.8–26.7], p<0.001) for patients with MDRO central-line bloodstream infections during 
a seven-year retrospective study at a 1250 bed academic medical center.238 Following these 
recommendations when caring for patients with indwelling devices would potentially mitigate 
MRSA and VRE CCCI. 
5.1.2: Aim 1 Strengths and Weaknesses 
We conducted a multi-year, multi-site, prospective, hospital-wide investigation including 
all species of VRE, comparisons of CCCI to multiple control groups, molecular analysis of 
pathogens and a separate analysis of patients with pathogens isolated on the same day and in the 
same specimen to determine the epidemiology of MRSA and VRE CCCI. While previous research 
has been conducted to determine risk factors for CCCI with these pathogens, none have been 
conducted with the totality of parameters included in our study, indicating the strength of our 
research.151–157  
 Our use of three control groups is a major strength of our study design. MRSA and VRE 
CCCI may occur through three different pathways: simultaneous acquisition of both organisms or 
acquisition of VRE or MRSA with subsequent acquisition of the other at a later time. Using three 
control groups of MRSA only, VRE only and no MRSA or VRE allows for an investigation of 
CCCI risk through all three pathways. One drawback of this design is the inability to statistically 
compare findings of associations between analyses, but this can be offset, in part, through 
qualitative comparisons such as observing the effect of the same variable in multiple models.239 
The restrictions on pathogen carriage among control groups also creates control groups which may 
not completely reflect the source population (all patients without MRSA and VRE CCCI), a 
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possible source of selection bias. These excluded patients likely make up a small proportion of 
control groups, limiting the effect of their exclusion.239 Furthermore, multiple comparisons would 
not be possible without their exclusions.239 
 Analyses including patients with MRSA and VRE isolates collected on the same day and 
in the same specimen is relevant to VRSA acquisition and is another strength of our study. For 
resistance gene transfer to occur, MRSA and VRE must be in close contact. Detecting both 
pathogens on the same day or in the same sample demonstrates their cohabitation and potential for 
gene transfer. The concordance of these analyses with our main findings provides some evidence 
for potential VRSA risk factors to be investigated among MRSA and VRE CCCI risk factors. 
 Other strengths are present in our study. Our source population was from healthcare 
facilities in southeastern Michigan, the region of the U.S. with the most VRSA cases. Determining 
risk factors of MRSA and VRE CCCI in this population adds to the understanding of why VRSA 
may be occurring in this region. A comparison of these factors to hospitalized patients outside of 
southeast Michigan may reveal a patient population more at risk for VRSA than elsewhere. Our 
molecular analysis was another strength. The molecular characteristics provided more evidence of 
healthcare exposure as a risk factor and could provide information as to why VRSA cases occurred 
more frequently in southeast Michigan versus the rest of the U.S. A multi-faceted approach to 
CCCI epidemiology provided us with additional evidence of healthcare exposure as a risk factor. 
Stepwise regression is a limitation of our study. This method of variable selection can lead 
to multiple problems including adjustment of inappropriate covariates and bias in the estimate of 
regression coefficients, especially with smaller samples, which can invalidate findings.189,190 We 
attempted to mitigate these potential sources of bias through our selection of variables included in 
the stepwise process. We used a prospective study design to identify new cases of CCCI. We 
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included variables in our analysis with a temporal relationship to CCCI which allows for the 
plausibility of causality. Use of a priori knowledge is another strategy for reducing bias with model 
seletion.240 As research into risk factors for CCCI is still limited, prior knowledge of characteristics 
for use in models is difficult. However, we included risk factors from prior research, as well as 
potential risk factors for VRSA and other MDRO risk factors to limit the potential for inappropriate 
inclusion of covariates.44,65,148,151–157,165,191 
5.1.3: Aim 1 Future Considerations 
Our MRSA and VRE CCCI investigation included a molecular analysis of MRSA isolates 
using multi-locus sequencing typing (MLST) to determine associations between sequence type 
and CCCI. Other sequencing methods may provide advantages over MLST, particularly whole 
genome sequencing (WGS). WGS provides the sequence for the entirety of the genome, including 
the core genome, which is present in all strains of a clade, and the accessory genome, which may 
be present in a subset of strains. Sequences produced during WGS can be used for traditional 
sequencing methods such as MLST but can also be used for more discriminatory methods, such 
as core-genome MLST and whole-genome MLST, to determine relationships between 
isolates.241,242 As WGS is used more frequently, relationships between strain types identified using 
these more discriminatory typing methods and other factors such as location of isolate acquisition 
(healthcare facilities vs. community), infection site or associations with comorbidities can be 
determined. These associations could provide additional evidence of risk factors for CCCI in our 
study. While of limited utility in our CCCI study, determining relationships between organisms 
can be of benefit in outbreak analysis or used in our hospital environmental contamination aim to 
determine the relationship between organisms isolated from patients and the environment. 
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WGS sequencing can provide additional information as well. In our CCCI study, we 
detected the presence of PVL genes, supplying additional evidence of healthcare exposure as a 
CCCI risk factor. Using WGS, the presence of other virulence genes can be identified, which can 
provide additional information regarding how an organism was acquired.243 WGS also allows for 
the identification of other genes including resistance genes.244 In our study, we could potentially 
identify vancomycin resistance genes in our MRSA isolates, providing information regarding the 
development of VRSA. As WGS costs have decreased, its application has become more 
practical.245 WGS provides the information garnered from older typing methods but also offers 
more discrimination in determining relationships between isolates and additional information 
regarding the presence of genes, which can inform mechanisms of organism acquisition and 
antibiotic susceptibility. 
Other avenues of research can be pursued relating to MRSA and VRE CCCI. While we 
investigated risk factors of MRSA and VRE CCCI, outcome analysis could also be useful in 
providing more support for implementing the recommendations discussed previously. Outcome 
measures such as mortality and length of stay have been collected with our data and can be 
evaluated for their relationship to CCCI. Outcome analysis for MRSA and VRE CCCI has received 
less attention than risk factor analysis and this additional work would add to this knowledge gap 
of MRSA and VRE CCCI.151,156  
 Our findings could also guide investigations into preventing CCCI. Healthcare exposure as 
a risk factor for CCCI may inform infection prevention and control strategies such as screening 
practices, cohorting and environmental cleaning practices for patients with other CCCI risk factors 
aside from healthcare exposure. Decolonization of MRSA carriers has demonstrated a reduced risk 
of MRSA infection.246 The CDC recommends decolonization on a case-by-case basis, including 
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for VRSA prevention.247,248 SHEA recommends decolonization targeted toward MRSA-colonized 
patients and patients at high risk of infection.249 Decolonization benefits for patients with risk 
factors for CCCI may mitigate the occurrence of CCCI and VRSA and is another potential avenue 
of investigation. 
 Broadly, the findings from this and other CCCI risk factor research can guide investigations 
regarding VRSA emergence. Characteristics increasing the likelihood of MRSA and VRE CCCI 
may be potential risk factors for VRSA acquisition as well. For example, eleven of the fourteen 
U.S. VRSA cases were in patients with diabetes.65,165 We also identified diabetes as a risk factor 
for CCCI in comparison with controls without MRSA or VRE. The mechanism through which 
diabetes may facilitate VRSA acquisition, perhaps through immune modification, chronic skin 
wounds, or causes vascular disease, could be of clinical interest. Although VRSA cases are still 
sparse, identifying patients at risk for VRSA would aid in mitigating its emergence. 
5.1.4: Aim 1 Summary 
We have demonstrated the role of healthcare exposure in MRSA and VRE CCCI. This 
knowledge can aid in prevention of MRSA and VRE CCCI acquisition and potentially alleviate 
the emergence of VRSA. Additional research on health outcomes related to CCCI and the 
relationship of risk factors to VRSA development can inform infection prevention policies and the 
direction of scarce resources. 
5.2: Aim 2 
5.2.1: Aim 2 Knowledge Added and Implications 
Healthcare-associated infections caused by MDRO are a common problem in U.S. 
hospitals.34 Preventing transmission of MDRO through the hospital environment remains a 
 99 
challenge, but has proven to be successful and cost-effective.97,195,196 Limited time and resources 
demand an efficient use of prevention practices. Determination of patient populations for whom 
targeted practices which would be most beneficial for reduction of environmental pathogen 
transmission would guide the application of these strategies. In chapter 3, we used latent class 
analysis, inputting observed patient characteristics, to identify a low functional status (LFS) patient 
type who contaminates their surrounding environment more frequently than high functional status 
(HFS) patients. 
Our identification of the role patient functional status plays in MDRO environmental 
contamination has significant public health implications. Patient functional status can be easily 
assessed by clinicians and can provide a means for identifying patients to whom additional 
infection prevention practices should be directed. Our findings build off previous research into 
patient characteristics associated with environmental contamination and shed light on potential 
mechanisms which contribute to this problem. We provide three potential mechanisms explaining 
increased contamination by LFS patients.  
First, hand and body site contamination have both been implicated in increased 
environmental contamination, demonstrating the importance of patient hygiene.82,110 Functionally 
limited patients may be unable to maintain their hygiene, potentially explaining our findings. The 
CDC recommends hospitalized patients maintain proper hand hygiene, which our findings 
support.250 236 Haverstick et al. observed a significant decrease in MRSA and VRE infections in a 
post-surgical step-down unit following the implementation of a patient hand hygiene education 
program, demonstrating this practice can improve patient outcomes.251 While hand hygiene for 
HFS patients could be addressed primarily through education, LFS patients may need additional 
assistance with hygiene practices which could be a low-cost prevention strategy. SHEA 
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recommends daily chlorhexidine bathing of ICU patients.237 Our findings support patient hygiene 
strategies such as daily chlorhexidine bathing for patients unable to maintain their personal 
hygiene. 
Second, bodily fluids may also play a role in increasing environmental contamination as 
well. MDRO in diarrhea, urine and wounds have been implicated in environmental 
contamination.109,199 In our study, mechanical ventilation was a marker for functional status. 
Mechanical ventilation provides a mechanism through which contaminated bodily fluids can 
contaminate the environment.  Suction of respiratory secretions during mechanical ventilation may 
contribute to contamination. Yu et al. observed significantly more bacterial contamination within 
100 cm of the endotracheal intubation site of ventilated patients when open suctioning was used 
compared to closed suctioning.252 Although the potential for environmental contamination by 
respiratory secretions exists, no specific recommendations are available for the prevention of 
environmental contamination from mechanical ventilation. This highlights the importance of other 
infection prevention strategies including hand hygiene, standard precautions and environmental 
decontamination for preventing environmental contamination when caring for mechanically 
ventilated patients. Guidance regarding measures to limit environmental contamination during 
mechanical ventilation could mitigate contamination with MDRO by LFS patients. 
Another mechanism of environmental contamination by LFS patients may be mediated 
through healthcare worker (HCW) interactions. LFS patients may require additional care from 
HCW compared to their HFS counterparts, such as for the maintenance of mechanical ventilation. 
HCW have been implicated in environmental transmission of pathogens with patients and the 
environment.38,192 Currently, the CDC recommends contact precautions for patients colonized with 
target MDRO and our findings support that recommendations, particularly for LFS patients.236 Our 
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findings also suggest that rooms with LFS MDRO carriers may benefit from more frequent 
cleaning targeting the immediate environment of the patient. The CDC does recommend 
prioritizing cleaning high-touch surfaces, especially those close to the patient, for any patient in 
contact precautions, which our findings support as well.236 To ensure these precautions are 
appropriately used, LFS patients may benefit from MDRO screening. No current screening 
recommendations are targeted toward this group. 
5.2.2: Aim 2 Strengths and Weaknesses 
Our use of LCA to determine functional status in this aim comes with strengths and 
weaknesses. As no one specific measurement can assess functional status, LCA allowed us to use 
several characteristics to categorize patients based on this unobserved trait. LCA also allowed us 
to identify associations between functional status and environmental contamination. Variable 
selection and class number determination for LCA can be done in a variety of often complicated 
methods. While our methodology was likely simplified, our use and agreement of both AIC and 
BIC to determine model fitness has been demonstrated to be appropriate.253 Our item choices also 
make logical sense for the identification of LFS patients. LCA also provides posterior probabilities 
for the likelihood of class membership for each individual. We used maximum-probability 
assignment, assigning each member to the class with the higher posterior probability. This method 
can cause attenuation of associations between latent classes and other variables due to potential 
misclassification of individuals in latent classes, although it does perform better in this regard than 
some other methods.205,254 However, we still detected significant findings with strong effect 
measures. The possibility of attenuation indicates a stronger association than we observed. 
Our study population was derived from a larger cleaning intervention trial which comes 
with strengths and weaknesses as it was not specifically designed for our purposes. One weakness 
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is the single environmental sampling time point for each MDRO identified during patient 
screening. Repeat sampling may provide the opportunity to determine the role of length of stay on 
environmental contamination, which we could not do. Our study did include a large sample of 
patients and sampling of five high-touch sites, allowing us to capture a large number of 
contamination events.  
The trial included an investigation of six organisms, which allowed us to assess total 
contamination as well as contamination with individual organisms to identify differences between 
species. However, another weakness was the lack of molecular analysis of isolates, allowing for 
the potential misidentification of relationships between isolates from patients and the environment 
which can cause misclassification bias of our results. Daily cleaning of the five high-touch surfaces 
used for environmental sampling reduced the possibility of misclassification. Fluorescent markers 
were used to determine the frequency of cleaning for a selected sample of these patients. Additional 
analysis of this data would aid in determining the thoroughness of cleaning for patients in this 
study. Ideally, the room would be cleaned and sampled prior to occupation by a new resident to 
ensure a lack of contamination, but this would be impractical in the clinical setting.  
Another weakness was the inconsistency of sampling times following detection of MDRO 
colonized patients, resulting in delays of environmental sampling for a small number of patients. 
We performed a sensitivity analysis to ensure patients with delays in sampling were not attenuating 
results through decolonization resulting in a lack of environmental contamination. Furthermore, 
MDRO colonization can be prolonged and result in shedding for months, indicating decolonization 
is unlikely for most patients over a period of days.83–85  
Lastly, the study was not designed to quantify MDRO at screening sites or in bodily fluids, 
detect MDRO on hands or other body sites, or include information on diarrhea among patients, all 
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factors with limited evidence indicating they could be risk factors for environmental 
contamination. These exclusions could result in confounding and bias our results. However, patient 
functionality may explain the occurrence of these factors, such as hand contamination, and 
adjustment would be inappropriate as they may act as intermediate variables. More research may 
be needed to understand these relationships. 
5.2.3: Aim 2 Future Considerations 
Our findings provide evidence to support future investigations regarding the impact of 
patient functional status on environmental contamination. Future research would benefit from a 
well-defined measurement of functional status which could assess mechanisms of contamination, 
such as hand contamination or contamination due to HCW interactions. Molecular testing to 
confirm relatedness of isolates and repeat sampling to assess time to contamination and capture 
contamination events would strengthen this research. Sampling from environmental sites further 
from the patient may provide additional information regarding the mechanisms through which the 
association of functional status and contamination occur.  
 Other research exploring the mechanisms of this association may provide guidance for 
infection prevention and control. Patient hygiene is an area that is understudied. SHEA 
recommends daily bathing of ICU patients with chlorhexidine. The implementation of such a 
strategy toward all LFS patients may mitigate MDRO environmental contamination and 
transmission. Determining the burden of pathogen contamination or colonization on the hands and 
bodies of LFS patients would inform whether patient hygiene influences environmental 
contamination by these patients. Investigations into possible benefits of hand or body hygiene for 
low functioning patients with regards to reducing environmental contamination would further 
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provide evidence for this mode of transmission. LFS patient hygiene can also be examined as a 
potential cost-effective strategy to prevent MDRO transmission and improve patient outcomes. 
 Interactions between HCW and LFS patients is another potential mechanism of 
environmental contamination to be evaluated. Comparisons between contamination of HCW by 
LFS and HFS patients is one way to gauge the impact of this interaction. Environmental sampling 
of sites distant from LFS patients but frequently contacted by HCW can demonstrate transmission 
of MDRO through HCW. Contamination of HCW during interactions with LFS patients may occur 
as well. These contamination events could result in transmission to other patients cared for by the 
same HCW, another potential target of investigation and intervention. 
 The role of bodily secretions among LFS patients, particularly those mechanically 
ventilated, can be explored as well to assess the contribution of these fluids to environmental 
contamination. Strategies to reduce excreted secretions during suctioning of ventilated patients can 
be investigated. Research on hygiene practices with regards to urine, stool and wounds for LFS 
patients could provide other targets of intervention. The inability of LFS patients to address these 
potential sources of contamination demands HCW vigilance and best practices should be 
determined. 
 Research regarding other infection prevention strategies geared toward LFS patients should 
be initiated. Strategies to improve cleaning of high-touch surfaces near LFS patients can be 
explored. The benefits of screening these patients for MDRO when not otherwise indicated can be 
examined to determine if identifying LFS MDRO carriers can allow for better prevention of 
MDRO transmission. These patients may also benefit from decolonization, which could also be 
investigated. The variety of potential mechanisms which may contribute to environmental 
contamination by LFS patients provides many potential directions for future research. 
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5.2.4: Aim 2 Summary 
We have detected the impact of patient functional status on environmental contamination. 
Our findings can aid in the development of strategies to disrupt transmission of MDRO through 
the environment due to their excessive contamination. Research into understanding the exact 
mechanisms of this association can further inform best practices to mitigate MDRO contamination 
and transmission. 
5.3: Aim 3 
5.3.1: Aim 3 Knowledge Added and Implications 
Children are an understudied population with regards to MDRO, but evidence suggests 
MDRO infections in this population may be increasing.115,116,118 MDRO carriage among child 
care attendees has been observed to be as high as 23% for ESBL-producers and 7% for 
MRSA.120–124  Child care presents a setting where MDRO transmission can occur due to shared 
environments and behaviors of attendees such as mouthing of toys and poor hygiene. In aim 3, 
we surveilled the environment of a child care center to determine the bioburden of fomites and 
the frequency of contamination with MDRO and viral pathogens. 
 We demonstrated a methodology that allows for surveillance of overall bioburden and viral 
and bacterial pathogens in child care centers (CCC). Our surveillance design provides a means to 
detect patterns of contamination for multiple pathogens and, for bacteria, confirmation of viability 
indicating infectious potential, informing environmental decontamination practices. Previous 
contamination investigations in CCC’s have targeted either bacterial or viral contamination but 
surveilling for both enhances knowledge regarding pathogen transmission through the 
environment in this setting.130–135,137–139,143 In particular, MDRO sampling has been lacking in this 
area of research and our study demonstrates a feasible method for surveilling these pathogens. 
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Sampling was performed within thirty minutes, allowing for data collection with minimal 
disruption for the CCC. The collection process was simple and requires minimal training for 
investigators. The sampling method permits sampling from a variety of sites within centers, 
allowing for comparisons of multiple materials and sites with different size, functionality and 
mobility. Future investigations with this study design can be applied to improve the understanding 
of environmental contamination in CCC’s. 
We identified sites where children play and wash with water as harboring the highest 
bioburden and being most frequently contaminated with MDRO and viral pathogens, a significant 
finding in CCC research. Previous investigations of CCC environmental contamination have 
neglected sampling from areas where children wash or play with water.130–135,137–139,143 The 
American Academy of Pediatrics, the American Public Health Association, and the National 
Resource Center for Health and Safety in Child Care and Early Education have published national 
recommendations regarding CCC environmental decontamination practices.127 For water tables, if 
flowing, potable, fresh water is not available, they recommend filling the table with fresh, potable 
water immediately before play begins and changing water if a new group of children plays at the 
table, even if the new group comes from the same room. The basin and toys used at the water table 
should be washed and sanitized at the end of the day. Children should wash their hands prior to 
water table play and hands should be free from cuts, scratches or sores. Our findings support these 
recommendations. They also recommend cleaning and disinfecting handwashing sinks at the end 
of the day. Our findings support this recommendation as sinks were another site with high 
bioburden. In Michigan, where the CCC studied is located, the Licensing and Regulatory Affairs 
(LARA) branch of the Michigan state government publishes licensing guidelines for Michigan 
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CCC’s.128 They provide no guidance for decontamination of water tables or sinks, which should 
be reconsidered. 
We identified other sites with excessive contamination as well which were not cleaned as 
frequently as other sites. Wood blocks harbored the highest bioburden among the toys. National 
recommendations include cleaning of toys which are mouthed or contaminated with other bodily 
secretions to be washed and sanitized by hand or cleaned in a dishwasher.127 However, they 
recommend not using toys which cannot be cleaned in this manner. Wood blocks may be damaged 
from this cleaning process and were not cleaned in the dishwasher with other toys in the CCC in 
our study. A potential alternative for cleaning may be to remove toys from circulation for a period 
of time to allow for a natural death of microorganisms. LARA provides no regulations for CCC’s 
regarding cleaning toys which should be reevaluated.128 
Frequent cleaning may also be responsible for the lower bioburden observed at the large 
tables compared to the imitation kitchen, even though the kitchen had a similar smooth surface to 
the tables. The other large tables were cleaned immediately prior to our sampling due to their use 
during group activities. This difference could demonstrate the benefit of cleaning these surfaces. 
National recommendations for decontamination of tables includes cleaning and sanitizing before 
and  after each use, which our findings support.127 LARA recommends washing tables before and 
after use for eating only.128  
Sites which may be difficult to clean can also result in more contamination. The building 
block table, which had an irregular surface, harbored a higher median bioburden than the other 
smooth tables at the CCC. This site poses a unique challenge due to the irregularity of its surface. 
Recommendations for cleaning of tables do not address irregular surfaces. These surfaces may 
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need additional guidelines regarding decontamination or centers should consider removing them 
if disinfection is not feasible. 
 With regard to all sites of high contamination identified in our study, child care providers 
may need to determine the benefit of these items and weigh them against their potential to harbor 
and transmit pathogens. These considerations should be given to items where children play with 
water, items with large irregular surfaces and items difficult to clean due to material type. Providers 
may consider items which are easier to disinfect but still provide educational and developmental 
benefits for children. 
5.3.2: Strengths and Weaknesses 
Our methodology for sample collection is a major strength for this study. We detected 
overall bioburden and the presence of both viral and bacterial pathogens, allowing for the 
assessment of contamination with multiple organisms of interest. However, we only investigated 
three MDRO and two viruses, but have samples stored from the study which could be used in 
future investigations. We sampled from fomites including a variety of material types, surface 
types, sizes and functionality, which aids in determining the types of fomite which could be 
responsible for pathogen transmission. Other sites could have been included in our analysis, such 
as floors (carpets, vinyl, etc.), cloth toys and play clothes to provide additional information 
regarding patterns of pathogen contamination. Repeat sampling from environmental sites allowed 
for the detection of patterns of contamination within the CCC’s. 
 Several limitations exist for this study as well. We did not perform confirmatory 
identification of MDRO detected using selective media. We have stored isolates and this 
confirmation can be performed when laboratory access improves following the COVID-19 
pandemic. However, the sensitivity and specificity of the media is high, indicating the possibility 
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of misidentifying pathogens was low.225–227 We did not culture viral samples to confirm the 
viability of detected viruses. Ganime et al. observed 50% viability of adenovirus from sites with 
PCR-detected adenovirus collected from hospital fomites, suggesting the presence of viral DNA 
detected in the environment may indicate viable adenovirus contamination to a certain degree.228 
Furthermore, sites with more frequent adenovirus contamination were also sites with higher 
bioburden, suggesting the DNA could be a marker for contamination.  
 Our study setting may also be a limitation, particularly with regards to generalizability. We 
collected samples from one room with a small class size of limited age range and a small number 
of staff. Variability may exist between classes, especially with those including children still using 
diapers. Other classes may have different cleaning protocols which could affect environmental 
contamination. No illness outbreaks occurred during the study period, which could alter the 
presence of pathogens in the environment. Including more classes with more students would allow 
for the ability to capture a larger variety of settings to investigate. 
5.3.3: Future Considerations 
The research presented demonstrates a strategy for environmental sampling in CCC’s. The 
next step would be to expand this research with a larger study. This extension would include 
multiple centers and classrooms with larger class sizes of wider age ranges and increased staff 
members. Additional fomites can be examined, including food preparation surfaces, diaper 
changing areas and flooring. Sampling from hands or screening attendees and staff for pathogens 
would provide additional information regarding the patterns and mechanisms of environmental 
contamination. The expansion could also add other pathogens of interest, such as target organisms 
implicated in illness outbreaks within specific centers. This methodology could potentially be 
applied for environmental surveillance in settings other than CCC’s as well. 
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 Other potential investigations could be guided by our specific findings. Sites where 
children wash and play with water have been ignored in previous research. Water tables would be 
of particular interest. The impact of changing water and cleaning basins and the immediate 
surroundings could be examined and would aid in the guidance of policies directed toward 
minimizing contamination at these sites. Irregular surfaces would be another target for future 
studies. Li et al. detected differences in contamination between smooth and irregular surfaces.214 
however, their focus was small objects like toys and utensils. Investigating larger surfaces which 
should be cleaned daily, such as the building block table in our study, would determine whether 
additional cleaning resources should be applied for these fomites. Removal of objects from 
circulation would be another research avenue which our findings provide support for exploring. 
Currently, no recommendations are provided for such actions for the purpose of 
decontamination.127,128 This practice could provide CCC’s with a strategy to prevent pathogen 
transmission that would be cheap and require limited time commitments from staff. The limited 
research on environmental contamination in CCC’s provides ample opportunity for gaps in 
knowledge to be filled and the research presented here can be built upon toward that goal. 
5.3.4: Aim 3 Summary 
We demonstrated a method of CCC environmental sampling which can guide infection 
prevention and control practices in these settings. The association of contamination with sites 
where children wash and play with water is a significant finding which adds to the public health 
knowledge regarding CCC’s. We also identified other potential areas of intervention, including 
irregular surfaces and objects which may be difficult to decontaminate using traditional methods. 
Our study design can be used to investigate these areas and other research objectives in child care 
settings. 
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5.4: Overall Implications 
MDRO are a global problem in healthcare. Preventing adverse outcomes from these 
organisms requires intervening on targets where MDRO transmission and acquisition can occur. 
In this dissertation, topics related to preventing MDRO acquisition and transmission were 
explored. In chapter 2, we identified risk factors for MRSA and VRE CCCI in hospitalized 
patients, a predecessor to VRSA acquisition, and determined healthcare exposure is a risk factor. 
In chapters 3 and 4, we investigated environmental contamination with MDRO. In chapter3, LFS 
patients were determined to be contaminating their surrounding environment more frequently 
among MDRO colonized inpatients. In chapter 4, we moved to the community setting to 
investigate MDRO environmental contamination in a CCC. We validated a methodology for 
detecting environmental contamination, including both viral and bacterial pathogens, which can 
be applied to large scale studies. We determined sites where children wash and play with water, 
sites with irregular surfaces and fomites difficult to clean with traditional methods were more 
contaminated than other sites, including with MDRO, informing decontamination practices in 
these facilities. The research presented here adds to the public health knowledge regarding MDRO 
acquisition and transmission and presents new paths of investigation to continue to combat the 
burden of these pathogens. 
The worldwide prevalence of MDRO, the difficulty to treat infections they cause and the 
risk of adverse health outcomes from these organisms necessitate ways to prevent MDRO 
acquisition and transmission. Interrupting MDRO transmission and acquisition requires 
interventions at multiple levels of settings and populations, which this dissertation presents. 
Although strategies may be targeted toward specific groups or settings, MDRO interventions in 
one group or setting may alleviate the burden in others. For example, we observed LFS patients 
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contaminated their environment more frequently in chapter 3. A patient hygiene intervention 
directed toward LFS patients may reduce the burden of contamination and provide indirect benefits 
to other patients not in this group. Prior room occupancy by an MDRO carrier is a risk factor for 
MDRO acquisition.92–94 Reducing contamination in the environment may reduce the risk of 
MDRO acquisition for the next occupant, particularly if that occupant has risk factors for MDRO 
acquisition as identified in chapter 2, such as having an indwelling medical device or recent 
antibiotic exposure. 
 These interventions may have other ramifications beyond the specific setting where they 
are implemented. Hospital floors are not isolated environments. Infection prevention in one unit 
of the hospital may alleviate MDRO prevalence in others. Patients moving between settings, such 
as general floors and critical care units may provide opportunities for MDRO transmission. During 
a 24-month, prospective study at three ICU in two Greek hospitals, Papadimitriou-Olivgeris et al. 
detected VRE in 71/497 (14.3%) patients screened.36 Of the 71, only 12 (16.9%) were admitted 
directly to the ICU without hospitalization, demonstrating the potential for MDRO introduction to 
the ICU from other hospital units. Referring back to the patient hygiene example, environmental 
contamination may be reduced through such an intervention. Preventing MDRO acquisition, such 
as through the previous patient hygiene example, may reduce MDRO contamination. A patient at 
high risk for MRSA and VRE co-colonization may subsequently reside in that room. A reduction 
in environmental contamination could prevent that patient from acquiring an MDRO and 
potentially transferring it elsewhere, such as a critical care unit.  
 Stepping back further, hospitals themselves are not isolated as well. In chapter 2, we 
identified admission from another healthcare facility as a CCCI risk factor when comparing CCCI 
patients to MRSA controls. The high-risk patient in the patient hygiene example may be spared 
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MRSA acquisition due to the intervention. If that patient is then transferred to another facility, the 
risk of acquiring VRE resulting in CCCI could be mitigated. The CDC recommendation to screen 
admitted patients transferred from facilities with known high MDRO prevalence is another 
example of an intervention which can aid in preventing transmission between facilities.236 A 
patient from a high MDRO prevalence facility with risk factors for MRSA and VRE CCCI might 
be an ideal candidate for MDRO screening. Interactions between and within healthcare centers 
demonstrate the importance of preventing MDRO acquisition and transmission for a single 
hospital or unit, but more broadly within the healthcare system. 
 In the community, interactions between settings occur as well. Hewlett et al. performed 
molecular analysis of MRSA isolates collected from attendees and employees of a CCC and their 
household members.123 Indistinguishable MRSA isolates were collected from an employee, the 
employee’s child who did not attend the CCC, and two children who did attend the CCC. The 
findings indicate the potential for MDRO to be transmitted between settings in the community. In 
chapter 4, we identified environmental sites with higher organism contamination which can inform 
cleaning and disinfection practices in CCC’s, such proper water table maintenance, reducing 
MDRO environmental contamination in these centers. Reduced contamination could result in 
reduced transmission, not only in the CCC, but to household members of CCC attendees and 
employees. Our findings may have broader implications than reduction of MDRO transmission 
within CCC’s. 
Healthcare and community settings interact as well. Riccio et al. followed 71 patients 
colonized with intestinal ESBL-producing Enterobacteriaceae discharged from five European 
university hospitals for up to four months.255 They identified 19 household transmission events of 
clonally related isolates, 13 from index patients to household members and six from household 
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members to index patients, with 1.18 transmissions/100 participant-weeks. These findings show 
transmission of MDRO from the hospital into the community is possible. Interventions in one 
setting, such as patient hygiene to reduce MDRO contamination in the hospital, may not only 
reduce transmission in that setting, but also between facilities or into the community. The findings 
presented in this dissertation can advise infection prevention practices resulting in a direct effect 
in the setting where they are implemented but may also have a far-reaching impact. 
Considering the intertwined nature of populations and settings where MDRO are 
transmitted, research aimed at characterizing the movement of MDRO between settings will aid 
in mitigating MDRO emergence. In Appendix A, a proposal is presented for developing a self-
collection method for VRE screening. Self-collection of these samples can make surveilling VRE 
in the community more practical. If valid, this method of screening could be applied to longitudinal 
surveillance of discharged hospitalized patients to determine the duration of colonization and 
potential for VRE transmission in the community. VRE surveillance within households and CCC’s 
could be conducted to discover patterns of transmission within and between these settings. Self-
screening can be another tool to better understand MDRO transmission and acquisition to aid in 
infection prevention and control. 
5.5: Concluding Remarks 
Antibiotic-resistant bacteria are common worldwide. These organisms are difficult to 
treat and cause substantial morbidity and mortality. A multi-faceted approach to prevention of 
MDRO transmission and acquisition is required across settings and populations. This dissertation 
identified targets for intervention , providing new paths for MDRO infection prevention and 
control as part of a larger approach to help mitigate the burden of MDRO. 
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Appendix: Development of a Self-Collection Screening Method to Identify Vancomycin-
Resistant Enterococcus Colonization 
 
A.1: Introduction, Motivation and Objectives 
Vancomycin-resistant enterococci (VRE) are among the most common healthcare-
associated pathogens in the U.S.145 Limited treatment options are available for VRE, resulting in 
poorer outcomes compared to their susceptible counterparts, including increased mortality, longer 
length of hospital stay and increased risk of infection recurrence.29,256,257 While the burden of VRE 
in healthcare facilities has encouraged extensive research in this setting, VRE in the community 
has received less attention. 
Most community-based, VRE studies are cross-sectional and limited by small sample sizes, 
restricting the analysis which can be performed using this data.49–52,258–266 However, these studies 
have demonstrated the presence of VRE in community settings, estimating the prevalence of 
asymptomatic colonization to be as high as 39%.49–52,258–266 
The presence of VRE in the community may be, in part, due to the movement of VRE 
carriers between healthcare and community settings. Baran et al. observed the prevalence of VRE 
among members of households of healthcare workers with direct patient contact from one Detroit, 
MI hospital was higher (7.3%) compared to the households of healthcare workers without patient 
contact (2.2%).267 This finding supports the hypothesis that VRE carriers in healthcare settings 
may introduce VRE into the community. Conversely, VRE carriers in the community may serve 
as a reservoir for VRE reintroduction into healthcare facilities. The prevalence of VRE 
colonization among newly admitted ICU patients from home was 10% in one Maryland hospital.268 
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However, these studies demonstrating the interaction between healthcare and community settings 
included fewer than 25 participants colonized with VRE, indicating the need for continued VRE 
research to validate this connection. 
One barrier to prospective, longitudinal studies of asymptomatic individuals in the 
community are the current methods of VRE colonization screening. VRE reside in the digestive 
tract of colonized individuals and are shed in fecal matter. The CDC recommends rectal or 
perirectal swabs or stool samples as the standard for VRE colonization screening.236 However, 
stool samples cannot always be conveniently returned to investigators from study participants in 
the community. Additionally, rectal and perirectal swabs require administration by a healthcare 
professional, limiting their utility in community-based research. An alternative to the current 
screening methods needs to be developed to better facilitate VRE research in the community. 
Rectal/perirectal self-collection is a possible alternative to current VRE screening methods. 
Although this method has not been validated for VRE colonization screening, rectal self-swabbing 
has been utilized for sexually transmitted infections research. Rectal self-collection was observed 
to be comparable to clinician-collected rectal screening for anal cytology and a variety of sexually 
transmitted pathogens.269–273 Rectal self-collection was feasible and acceptable to perform for 
study participants.271,274–276 In addition to the feasibility and acceptability, some participants may 
be more amenable to self-collection compared to clinician-collection for screening. Among 
women who preferred self over provider anal HPV sampling in one Puerto Rican study, 28% felt 
less embarrassed and 69% felt more comfortable with self-sampling compared to clinician-
sampling.272 The successful implementation of rectal self-screening in sexually transmitted 
infection research demonstrates the potential utility of this method for VRE screening. 
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Other sampling sites may provide convenient targets for self-screening as well. In a 2010 
study sampling at six different body sites, inguinal sampling was demonstrated to be as effective 
as perirectal swabbing for multidrug resistant organism (MDRO) screening.277 Investigators 
observed similar results in a 2016 study comparing rectal and inguinal swabbing for MDRO 
screening, including VRE.278 The inguinal region is easily accessible for self-sampling and may 
be an additional viable alternative to rectal/perirectal swabbing. 
Current VRE screening methods may be impractical to conduct on a large scale in the 
community. The proposed study aims to develop a new sampling method using self-collected 
perirectal wipes to overcome the limitations of traditional VRE screening methods. 
A.2: Specific Aims and Research Activities 
Specific Aim 1: Compare the performance of a clinician-collected perirectal swab versus a self-
collected perirectal wipe for the detection of VRE colonization 
Specific Aim 2: Identify the acceptability and feasibility of self-collecting perirectal wipes for 
VRE colonization screening among participants. 
Research Activities  
Eligible inpatients at University Hospital in Ann Arbor, MI will be identified, consented 
and enrolled and immediately instructed on how to self-collect a perirectal wipe for specimen 
collection immediately following enrollment. Specimens from other body and environmental sites 
will be collected by researchers and will be processed along with the self-collected specimen for 
the identification of VRE. These findings will be compared to clinician-collected rectal/perirectal 
surveillance swabs obtained during the same admission to validate the self-collection method. 
Participants will also be surveyed regarding the acceptability and feasibility to perform the self-
collection. This work will be performed by myself or other investigators whom I will train. 
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A.3: Research Materials and Methods 
Specific Aim 1 
Study Setting and Subjects 
Fifty subjects will be recruited from the University Hospital in Ann Arbor, MI, part of the 
University of Michigan Medicine System. As part of the hospital’s active surveillance for VRE, 
rectal/perirectal swabs are used to screen high-risk inpatients for VRE upon admission and 
subsequent weekly screens given an initial negative screen. Criteria for eligibility include: positive 
VRE screen, 18 years of age and older, alert mental status, and provision of informed consent to 
participate in the study. Individuals with perirectal skin disruption or reduced immune function, 
indicated by neutropenia, will be excluded. Patients with a positive VRE screen will be identified 
using electronic medical records (MiChart). 
Data Collection 
Patient data will be abstracted from patient medical records and will include demographics 
(age, race, gender), patient clinical information (reason for admission, comorbidities, indwelling 
devices) and surveillance culture information (surveillance organism identification, antibiotic 
susceptibility profile). 
Clinician-collected rectal/perirectal swabs 
The sample collection process is outlined in Figure A-1. The clinician-collected 
rectal/perirectal swabs will be obtained as part of the standard clinical course by hospital staff and 
processed in the hospital clinical microbiology laboratory per hospital protocol prior to enrollment 
of the patient in the study. This swab will be considered the gold standard for VRE detection. 
Perirectal wipe 
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Immediately following consent into the study of a VRE positive patient, a member of the 
study team will instruct the patient on how to collect a sample using a perirectal wipe. Participants 
will be provided verbal, written and diagrammatic instructions for self-collection. The participant 
will wipe a moistened square of filter paper over the participant’s perirectal region. Following 
sample collection, each perirectal wipe will be placed in a medium for short-term storage. 
Specimens will be agitated and cultured on VRESelect within 72 hours of collection. All wipes 
will be refrigerated at 4°C prior to culturing and frozen at -80°C for long-term storage. 
Investigator collected swabs 
All swabs to be collected by the investigative team are listed in Table A-1. These swabs 
will be collected following the participant self-collection of the perirectal wipe. Inguinal swabs 
may provide another alternative VRE screening method and will be collected. Hand and 
environmental swabs will be collected to quantify the frequency of their contamination among 
VRE colonized individuals as both play a role in VRE transmission. Specimens will be placed in 
a medium for short-term storage and will be cultured on VRESelect within 72 hours of collection. 
All investigator-collected swabs will be stored in the same manner as the perirectal wipes. 
Statistical Considerations 
Sensitivity of the perirectal wipe, inguinal swab and hand swab will be determined, using 
the clinician-collected rectal/perirectal swab for comparison. Patients with a positive VRE screen 
as identified by the clinician-collected swab will be eligible for the study. However, the results of 
this screen will not be known for 24-48 hours following the sample collection. This processing 
time will result in a delay between the collection of this screening swab and the identification and 
subsequent enrollment into the study of eligible patients. This delay may result in a loss of 
colonization with VRE in the study participants. However, the conversion rate of positive to 
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negative VRE screens for inpatients at University Hospital is less than 1% daily (unpublished 
data), indicating the delay between clinician and self-sampling will have a minimal impact on 
sensitivity. The positive VRE screen requirement will also limit the statistical analysis to 
sensitivity only; specificity, positive and negative prediction values and measures of agreement 
will not be calculated. For an expected sensitivity of 80%, 50 subjects will be required to obtain a 
confidence interval of ±11.1% with α=0.05 (Figure A-2).279 A sample size of 50 will be feasible 
to obtain within six months using the entire hospital population (personal communication, 
unpublished data). The frequency of hand and environmental contamination will be assessed 
individually. Environmental contamination data will also be stratified by hand contamination 
status. 
Specific Aim 2 
Sample and Data Collection 
All subjects included in specific aim 1 will be eligible for specific aim 2. Surveys will occur 
in University Hospital. Following the collection of all samples, participants will complete five-
item Likert scale questions regarding the acceptability and comfort for undergoing self-collection 
of specimens and the feasibility of the procedure. Each participant’s preference of collection 
method, comparing self- and clinician-collected techniques, will be recorded. Finally, the 
willingness of participants to participate in a household study, which would include home visits 
by investigators and swabs of household members and the environment, will be assessed to inform 
potential future research. 
Statistical Considerations 
The proportion of participants who identify self-collection as acceptable and feasible to 




Risk to the participants will be minimal. There will be a low risk of perirectal abrasions 
due to the perirectal wipes. 
Laboratory Safety 
All laboratory analysis will be performed in the laboratory of Dr. Emily Martin at the 
University of Michigan School of Public Health, a Biosafety Level 2 laboratory specifically 
designed for the safe analysis of pathogens which pose a moderate hazard to personnel (e.g. 
VRE). Laboratory work with the pathogen will be conducted in a biological safety cabinet and 
personnel will wear appropriate personal protective equipment (gloves, goggles, laboratory 




Figure A-1: Flow Chart of Enrollment and Data Collection for the Study 
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Table A-1: Investigator-Collected Swabs. 
 
  
Swab Type Swab Description 
Inguinal A moistened swab will be moved over the participant’s left and right inguinal crease. 
Hand A moistened swab will be moved over the participant’s palms, finger webs and fingertips 
on both hands 
Call Button A moistened swab will be moved over the call button in the participant’s room. 
Bedrail A moistened swab will be moved over a predefined 50 cm2 area of the participant’s 
bedrail. 




Figure A-2: Power Calculation for Sensitivity of Self-Collected Perianal Wipes 
Expected Sensitivity: 0.8 
Critical Score for Significance Threshold of 0.05: 1.96 
Target Sample Size: 50 
Confidence Interval Width = 11.1% 
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